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Summary 
Animal models have long existed as part of the canonical approach to study a wide array of 
human infectious pathogens such as Mycobacterium tuberculosis (Mtb), the causative agent of 
tuberculosis (TB) disease. These models have served reasonably well in understanding the 
heterogeneity of pulmonary granulomas which are the main pathological hallmark of TB in 
humans. Nevertheless, there are several differences between the human immune system and 
the immune system of these species that play a role in TB pathogenesis. Ergo, in this thesis: a 
small animal model capable of delineating the human immune response in regards to TB 
granuloma heterogeneity is introduced which can serve as a pre-clinical drug platform. The 
NOD/SCID/IL-2 receptor gamma null (NSG) mouse is an immunodeficient strain capable of 
supporting human cell engraftment and was thus supplemented with human fetal liver derived 
stem cells.  Upon human immune system (HIS) reconstitution, HIS NSG mice were infected with 
ultra-low dose aerosolized Mtb. HIS NSG mice developed a range of lung lesions; in particular 
caseous necrotic granulomas, with a cellular phenotypic spatial-organization similar to that 
observed in certain TB patients. The core consisted of neutrophilic and monocytic cellular 
debris, with an inner rim that consisted of elongated macrophages, and an outer lymphocyte 
cuff that consisted of T and B cells. In addition, disseminated TB was observed in other organs 
including spleen, liver, kidney and bone marrow. Furthermore, parameters such as cell 
phenotype, immune and inflammatory biomolecules and spatial-cellular organization were 
assessed as the disease progressed, leading to the observation that a primarily proinflammatory 
immune response was generated. This thesis shows that the HIS NSG mouse can provide in vivo 
validation of prior TB studies with focus on the human immune response. Finally, the HIS NSG 
mouse lays the groundwork as a novel animal model for investigating TB pathogenesis, TB drug 
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Zusammenfassung 
Tiermodelle existieren seit langem als Teil des kanonischen Ansatzes, um eine breite Palette von 
humanen infektiösen Pathogenen wie Mycobacterium tuberculosis (Mtb), dem Erreger der 
Tuberkulose (TB) -Krankheit, zu untersuchen. Diese Modelle haben einigermaßen gut im 
Verständnis der pulmonalen Granulom Heterogenität, die die wichtigsten physiologischen 
Kennzeichen der TB bei Menschen. Dennoch gibt es einige Unterschiede zwischen dem 
menschlichen Immunsystem und dem Immunsystem dieser Arten, die eine Rolle bei der TB-
Pathogenese spielen könnten. Ergo, in dieser These; Ein kleines Tiermodell, das in der Lage ist, 
die menschliche Immunantwort in Bezug auf TB-Granulom-Heterogenität abzugrenzen und als 
präklinische Arzneimittelplattform zu dienen, eingeführt wird. Die NOD/SCID/IL-2-Rezeptor-
Gamma-NULL (NSG) -Maus ist ein immundefizienter Stamm, der in der Lage ist, die menschliche 
Zellentransplantation zu unterstützen, und wurde somit mit menschlichen fetalen Leber-
abgeleiteten Stammzellen injiziert. Nach dem humanen Immunsystem (HIS) Rekonstitution 
wurde HIS NSG mit Ultra-Low Dose Aerosol-TB infiziert. HIS NSG-Mäuse entwickelten eine Reihe 
von Lungenläsionen; Insbesondere fallende nekrotische Granulome, mit einer zellulären 
phänotypischen Raumorganisation ähnlich denen, die bei einigen TB-Patienten beobachtet 
wurden. Der Kern bestand aus neutrophilen und Makrophagen-Zelltrümmern; Mit einem 
inneren Rand, der aus langgestreckten Makrophagen bestand, und eine äußere 
Lymphozytenmanschette, die aus T- und B-Zellen bestand. Darüber hinaus wurde disseminiertes 
TB in anderen Organen wie Milz, Leber, Niere und Knochenmark beobachtet. Darüber hinaus 
wurden Parameter wie Zellphänotyp, Immun- und Entzündungsbiomoleküle und räumlich-
zelluläre Organisation als fortschreitende Krankheit beurteilt, was zur Beobachtung führte, dass 
eine meist proinflammatorische Immunantwort erzeugt wurde. Diese These zeigt, dass die HIS-
NSG-Maus in vivo-Bestätigung mit einem menschlichen Immunfokus von früheren TB-Studien 
liefern kann. Darüber hinaus legt die HIS NSG-Maus die Grundlage für ein neuartiges Tiermodell 
zur Untersuchung der TB-Pathogenese, der TB-Arzneimittelentwicklung und schließlich der HIV-
TB-Coinfektion. 
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1. Introduction 
1.1 Fundamentals of Tuberculosis 
In Berlin, on March 24 1882, Robert Koch presented his findings on an etiologic agent called 
Mycobacterium tuberculosis (Mtb) as the primary cause of the tuberculosis (TB) disease in 
humans in a presentation titled “Ueber Tuberculose” (1). Paul Ehrlich is quoted as stating that 
this presentation was "my single greatest scientific experience" (2) expressing the fascination 
scientists of that time period had with this deadly disease (3). 
 More than 133 years later, this fascination still persists as 1.7 billion individuals are estimated 
to be latently Mtb infected. This means that the human immune system is quite capable of 
containing the pathogen but inefficient at eradicating it (4, Figure 4). Infected individuals have a 
10% lifetime risk of developing disease but a vast number of the infected individuals are at risk 
for reactivated TB once the immune system weakens. In 2015, there were 10.4 million new TB 
cases (Figure 1) and of this number 1.2 million were human immunodeficiency 
virus/tuberculosis (HIV-TB) coinfected (Figure 2). Coinfection with both pathogens dramatically 
increases the risk of developing TB and 400,000 out of 1.8 million TB deaths in 2015 were due to 
HIV coinfection (Figure 3). In 2015, there were an estimated 2.9 million cases and 510,000 TB 
deaths among women as well as an estimated 530,000 cases and 80,000 deaths among children 
(4).  
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Figure1.  Epidemiology of all forms of new TB cases reported in 2015. (Source: WHO Global TB report, 
2016) 
 
Figure2.  Prevalence of HIV in new TB cases reported in 2015. (Source: WHO Global TB report, 2016) 
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Figure3.  Estimated TB deaths excluding HIV-TB reported in 2015. (Source: WHO Global TB report, 2016) 
The number of TB cases and associated deaths remains abysmally large due to a suboptimal 
vaccine, difficulty in diagnosing the disease and intermittent compliance to anti tuberculosis 
drug therapy. The currently administered Bacille Calmette- Guérin (BCG) vaccine, which is an 
attenuated strain of the virulent Mycobacterium bovis (cattle TB) partially, protects infants but 
not adults against severe tuberculosis. Moreover, BCG faces safety issues in infants with HIV 
infection (4) as HIV infection abrogates the BCG- specific T cell responses in these infants and 
causes BCG-osis, a form of disseminated BCG (5).  
Presently, there are various efforts to improve BCG vaccine efficacy (6). One of these efforts 
entails modifying BCG by the expression of a listeriolysin gene (hly) from Listeria monocytogenes 
and removing from the chromosome urease c gene (rBCGΔureC:Hly+) (7). This recombinant BCG 
vaccine also known as VPM1002 was generated by the Kaufmann laboratory and has been 
shown to provide better protection than parental BCG against TB by inducing type 1 and type 17 
T cell cytokines in mice (8). In mice it has also been observed that apoptotic vesicles from 
VPM1002 infected macrophages induced greater multifunctional CD4+ and CD8+ T cell 
responses than parental BCG (9). In addition, VPM1002 is safer than BCG in 
immunocompromised mice (7) and is in Phase II trials for safety and immunogenicity in 
newborns (10). VPM1002 is currently undergoing Phase IIb trials for safety and immunogenicity 
Frida T. Arrey                                                                                                                          Doctoral thesis 
 15 
in HIV exposed and un-exposed infants (11). VPM1002 will soon be in phase III trials for 
protection against recurrence of TB after drug treatments in adults (Personal communication 
from Professor Kaufmann). 
A new vaccine should also aim for low interference with TB diagnostics. One of the means by 
which TB is diagnosed is by purified protein derivative (PPD) skin test. PPD tuberculin is a 
precipitate of Mtb (12). It is administered intra-dermaly and the subsequent skin swelling 
diameter is measured to gauge if there is a cellular immune response to Mtb. Basically, a greater 
than 10mm swelling is an indicator for TB. However, the non-specificity for Mtb of PPD permits 
it to cross react in BCG vaccinated individuals complicating diagnosis. The false positivity 
generated requires further testing by chest X-rays and Ziehl-Neelsen sputum testing (13). Ziehl-
Neelsen acid fast is a stain that binds to the mycolic acids in the bacteria cell envelope aiding in 
Mtb visualization in sputum samples by light microscopy. The Ziehl-Neelsen test is limited by the 
difficulty in getting sputum from patients and the need for a high bacterial load in these samples 
for the test to be efficient. Subsequently, some active TB patients appear smear negative, and 
are thus the origin of 15 to 20% of transmission cases (83). 
Therefore, another diagnostic method that is employed is the Interferon-Gamma Release Assays 
(IGRAs). Two popular IGRAs are the QuantiFERON TB gold test (15) and the TB-Elispot test (14). 
This assay determines the amount of interferon-gamma (IFNγ) released by T lymphocytes in a 
suspected TB patient’s blood when mixed with certain Mtb antigens. These antigens are 6 kDa 
early secretory antigenic target (ESAT-6) and 10 kDa culture filtrate antigen (CFP-10). The genes 
encoding for these antigens are situated in region of difference 1 (RD1) of Mtb which is not 
present in BCG. Hence IGRAs are not affected by the BCG vaccine, but are affected by cross 
reactivity with M. africanum or M. marinum which also contain ESAT-6 and CFP-10. Lately, 
biomarkers have been proposed as the next line in the diagnostic arsenal. A biomarker is 
defined as a biological characteristic that is objectively measured and evaluated as an indicator 
of physiological or pathological processes (16). Biomarkers or bio signatures are in the form of 
transcriptomic, proteomic, metabolic profiling (17, 18) or epigenetic marks (19). Recently, a 
blood transcriptomic study showed that active TB patients have a neutrophil-driven interferon 
gene profile in comparison to systemic lupus erythematosus (SLE) patients that had a plasma 
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cell driven interferon profile (20). However, Maertzdorf J. and colleagues from the Kaufmann 
laboratory examined sarciodiosis patients (which have similar lung pathology to TB) to active TB 
patients, and observed that these two diseases have a similar interferon signature (21). To 
further discriminate between TB, healthy volunteers and other lung diseases, Maertzdorf J. and 
colleagues from the Kaufmann laboratory further examined gene sets in conjunction with 
certain algorithms. They observed that 4 particular genes could discriminate between these two 
groups. These genes were GBP1, ID3, P2RY14 and IFITM3 (248). Biomarkers are thus a promising 
diagnostic measure that will eventually provide a framework that will aid in determining which 
form of TB a patient has, thus giving further confidence in implementing the right therapy. 
The therapy administered when drug susceptible TB is suspected consists of rifampicin, 
isoniazid, pyrazinamide and ethambutol given daily or intermittently for two months, followed 
by rifampin and isoniazid for four months. This regimen has been consistently given with few 
changes for the past 15 years (22). These drugs act by having an inhibitory effect on certain 
enzymes involved in cell wall biosynthesis, nucleic acid metabolism and protein synthesis or by 
disrupting the membrane structure. For example, rifampicin inhibits bacteria DNA-dependent 
RNA polymerase which further prevents bacteria DNA-dependent RNA synthesis (249). 
Unfortunately, poor regimen compliance occurs in low-income settings where therapeutic drug 
options are expensive and patients experience harsh side effects. In addition there is a challenge 
in treating HIV-TB patients as certain drugs such as rifampin interact with protease inhibitors 
thus reducing their effect on HIV (250). This contributes to the rise of multi-drug resistant 
strains (MDR-TB) and extensively drug resistant strains of Mtb (XDR-TB) via de novo mutations 
(4, 251). This is reflected by the 2015 numbers of an estimated 170,000 MDR-TB deaths and 
450,000 MDR-TB incidence cases. In addition, XDR-TB has been detected in 105 countries (4). 
This requires the use of the diagnostic assay GeneExpert Mtb/Rif, which is a nucleic based assay 
that detects the presence of Mtb in sputum but also the rpoB gene that is responsible for 
rifampicin resistance (23). Hence, injectable agents such as kanamycin or amikacin or 
fluoroquinoles such as moxifloxacin are administered if susceptibility to these antibiotics is 
suspected (22). Lung surgical resection is another intervention to alleviate MDR-TB and XDR-TB 
(24). Currently, there have been reported cases of totally drug resistant TB (TDR-TB) (25).  
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This distressing scenario and the recent failed phase three drug trials of using fluoroquinoles in 
combination with other anti-TB drugs to shorten the time course from 6 months to 4 months by 
three independent groups, underscores the urgent need for new antibiotics or alternative 
treatment options for TB (26, 27 and 28). New antibiotics such as linezolid which has been used 
for skin infections and pneumonia due to methicillin-resistant Staphylococcus aureus have been 
integrated in new TB clinical trials. These clinical trials focused on MDR-TB and XDR-TB patients. 
Most patients (34 out of 39), had a negative sputum conversion within 6 months after linezolid 
was added to their drug regimen (29). In addition, positron emission tomography (PET) and 
compututerized tomography (CT) imaging revealed reductions in pulmonary pathology in 
macaques with active TB and patients with XDR-TB that followed a linezolid added drug regimen 
(30). Another antibiotic regimen that has shown promise and is presently in phase 3 trials (252) 
is a three drug regimen comprised of pretomanid (Pa), moxifloxacin (M) and pyrazinamide (Z). 
The PaMZ combination in a phase 2b trial was found to be effective not only against drug-
susceptible TB, but also MDR-TB and had TB-negative sputum after eight weeks (253). PaMZ 
regimen is also of great interest due to its potential use in HIV-TB patients as this regimen does 
not contain rifampicin. 
The eventual likelihood of any new antibiotic to lose susceptibility in the short term is low, but 
indiscriminate administration of the drug will increase the probability of drug resistance to 
develop in the greater population in the long term. Therefore, host directed therapies (HDTs) 
have been proposed as an adjunct or alternative to traditional antibiotics (31). In the pre-
antibiotic era, TB patients were sent to sanatoriums to get rest, fresh air, good nutrition and 
sunlight (32). This was essentially a means by which the body attempted to cure itself by 
resolving inflammatory pathways, inhibiting inflammation, reduce lung damage, induce 
autophagy and induce antimicrobial peptides. A basic example of HDTs is Vitamin D which is 
acquired from sunlight and supplementation. Others are repurposed drugs which can be 
brought through clinical trials quickly (382). Vitamin D induces production of cathelcidin and 
mediates initiation of autophagy via interferon gamma (IFN-γ), interleukin-15 (IL-15) and IL-32 in 
human macrophages (33, 34). New antibiotic regimens and various HDTs are currently 
undergoing in vivo validation in animal models and are in early stage human clinical trials (31).  
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1.2 Animal models of Tuberculosis 
The 1800s till the 1960s is considered as the main pre-antibiotic era whence human lung TB 
samples were primarily gathered from autopsies (254). Whereas, in the post-antbiotic era, most 
human lung TB samples are gathered from resected MDR/XDR TB surgeries (232). Consequently, 
knowledge of various biological processes that occur in humans has been acquired by carrying 
out experimental studies in animal models, particularly in rodents (36). In the field of TB 
research, Robert Koch described naturally occurring TB in a variety of animal species and he 
successfully infected mice, rats, guinea pigs, rabbits, hedgehogs, hamsters, cats and dogs with 
the tubercle bacillus (1, 35). Hence, animal experiments were instrumental for the discovery and 
scientific proof of the etiologic agent of TB. Mtb infection in experimental animals can produce a 
diversity of outcomes therefore, a prominent method to compare the state of infection across 
the different animal models in relation to human disease is by examining the pathological 
hallmark of Mtb infection - the granuloma (Figure 4 and Figure 7). 
Mtb infections starts with the inhalation of bacilli, either in an aerosol droplet generated by the 
cough or sneezes of an active TB patient and is followed by the arrival of the bacteria at the lung 
alveolar space. Mtb is then phagocytosed by the alveolar macrophages. A pro-inflammatory 
response is generated, which triggers the infected cells to migrate into the underlying 
epithelium. Concurrently, monocytes, neutrophils and dendritic cells are recruited from the 
circulation to the infection site, while new microvascular networks are formed. Granuloma 
associated macrophages (GAMs) undergo a differentiation program to form epitheloid cells, 
multi-nucleated giant cells and foamy cells containing lipids (37, 168). Subsequently, 
lymphocytes are recruited to the GAMs periphery. Further granuloma stratification occurs by 
the deposition of extracellular matrix material by fibroblasts outside the macrophage layer. A 
good number of the granulomas remain in this state, but a triggering event such as 
immunosupression due to malnutrition (38) initiates vascularization loss which renders the 
granuloma hypoxic. This leads to increased necrosis and caseation in the granuloma and in 
some cases cavitation (255). Other forms of lung inflammation that occur are tuberculous 
pneumonia while in other situations, spontaneous lung healing leads to calcification and fibrosis 
of the granuloma which may be sterile or contain few bacteria (Figure 4 and Figure 5). 





























Blue collagenous stain 
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Frida T. Arrey                                                                                                                          Doctoral thesis 
 21 
Details on the various animal models (39) used to recapitulate lung granuloma development in 
consideration of the parameters stated in Table 1 have been summarized in the following 
paragraphs. 
Infection route Aerosol, intratracheal or intradermal 
Inoculums size Ultra-low dose: 15 bacilli – 30 bacilli 
Low to mid dose: 100-250 colony forming unit 
(CFU) 
high dose: 1000 CFU - 106bacilli 
Bacterial strain Mtb lab strain H37RV or Erdman, Mtb clinical 
isolate Beijjing or CDC1551, M. africanum , M. 
bovis, M. marinium, M. caprae 
Animal model Mouse, guinea pig, rabbit, zebra fish, cattle or 
non-human primate 
Mouse strain C57BL/6, Balb C, Nos2-/-, C3HeB/FeJ 
Table1. Factors to consider in Mtb lung granuloma development studies 
Non-human primates 
Non-human primates (NHPs) have been used in TB research for many years’ especially in 
regards to natural outbreaks, vaccine and drug efficacy studies. The cynomolgus macaques and 
common marmoset are two of the most commonly used NHP species. The NHP is the model out 
of all the animal models that best mimics the spectrum observed in human tuberculosis. These 
NHPs upon infection by using a bronchoscope or fitted air mask (15-250 CFU) develop a range of 
lesion types similar to that observed in human disease (39, 40) (Figure 7). These NHPs have 
been infected with lab strain Mtb Erdman, clinical isolates (Mtb Beijing and Mtb CDC 1551) and 
M. africanum. NHP infection with various bacteria strains precisely delineates differences 
between these strains. Due to cross specificity, human reagents can be used in NHPs studies. In 
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addition, NHPs can be infected with Simian Immune deficiency virus (SIV) which opens up 
avenues for SIV-TB co infection which is similar to HIV-TB co infection in humans (41). Diagnostic 
tools such as PET/CT with probes like 2-deoxy-2-(18F)-fluoro-D-glucose (FDG); can be employed 
to follow one animal throughout a drug evaluation study (30). Additionally, common marmosets 
have a tendency to birth twins which are used to appraise the reproducibility or differences in 
parallel infection studies (42). Limitations to the widespread use of NHPs in tuberculosis 
research are; ethical constrains, expensive biosafety facilities, restrictive animal numbers and 
lack of dedicated veterinarian staff. 
Guinea pig and rabbit 
Similarly to NHPs, guinea pigs and rabbits (43, 44) have been used in TB research for several 
years but due to a rareness of immunology reagents their use has been limited. Nevertheless, 
guinea pigs and rabbits are used to study lung pathology upon Mtb infection as they produce 
human-like necrotic granulomas (Figure 7). Guinea pigs are highly susceptible to Mtb (aerosol 
dose of 20 CFU) while rabbits are quite resistant (aerosol dose of 106 bacilli). In guinea pigs, the 
caseum remains hard, while the caseum of rabbit granulomas undergoes softening or 
liquefaction as observed in human granulomas (45). Pathological differences caused by different 
Mtb clinical strains are also observed in the guinea pig and rabbit (46, 47).  
Cattle 
In natura, Mycobacterium bovis (M. bovis) is the etiological agent responsible for tuberculosis in 
cattle. Other mammalian livestock such as goats and sheep get infected with Mycobacterium 
caprae (48). Therefore, in addition to natural transmission studies, cattle in experimental 
conditions have been used to study necrotic granulomas as these are similar to human 
granulomas caused by Mtb (49).  
Zebra fish 
As M. bovis is a more natural way to infect cattle, likewise, Mycobacterium marinium (M. 
marinium), an aquatic genetic relative to Mtb is used to infect zebrafish embryos. Necrotic 
granulomas which appear to recapitulate human caseous granulomas develop (45). Moreover, 
Frida T. Arrey                                                                                                                          Doctoral thesis 
 23 
zebrafish embryos are transparent, which provides a means by which the dynamics of primary 
granuloma formation and dissemination to generate new secondary granulomas during the 
innate immunity phase of the infection can be visualized in real time (50). Limitations of the 
zebrafish embryo model are the lack of lymphocytes and hence lack acquired antigen specific 
immunity and lack of lung structure. 
Mouse 
Mice as experimental animals are inexpensive, easy to handle, have a vast range of genetic 
variant strains (36) and have a large number of immunological tools and reagents (35). Even 
though the mouse is not a natural host for Mtb, two of the common mouse lab strains used in 
TB research are the C57BL/6 and BalbC mouse. In order to investigate lung pathology, these 
mouse strains have been infected via aerosol or intratrachealy with 100 CFU to 4000 CFU of lab 
or clinical Mtb strains. The granuloma that develops in the C57BL/6 and BalbC mouse is a loose 
aggregate of macrophages and T cells and does not have a caseous necrotic center (51) (Figure 6 
and Figure 7). 
 
Figure6. Schematic depiction of the different granuloma phenotypes observed in humans and in the 
common laboratory mouse (Source: Courtesy of Professor S.H.E. Kaufmann) 





Figure7. Haematoxylin and eosin TB granuloma tissue sections from various animal models in 
comparison to human samples. First two columns represent non-necrotizing granulomas. Last two 
columns represent caseous necrotic hypoxic (brown stain) granulomas. (Source: Flynn/Barry, 2012) 
 
              Non-necrotizing granuloma                Necrotizing granuloma 
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In light of this, certain mouse strains that could develop necrotic granulomas similar to ones 
that are observed in humans have been subsequently generated. These are IL-13/IL-4ra 
transgenic mouse (257), interferon-gamma knock out mouse (259), I/st mouse strain (260), 
CBA/J mouse (258), Nos2 knockout mouse (54) and the C3HEB/FeJ (53) mouse which is a 
descendant strain from the CBA/J mouse. All these strains with certain perturbations develop 
necrotic granulomas. For example Reece S. and colleagues from the Kaufmann laboratory 
established a mouse TB model by using the mouse strain Nos2-/- which is deficient in inducible 
nitric oxide (iNOS). This mouse strain upon ear intradermal infection (104 Mtb H37RV) and 
blockage of tumor necrosis factor alpha (TNF-α) or IFN-γ, develops caseous hypoxic lung 
granulomas (54, 261) (Figure 9). The more established necrotic granuloma model is the 
C3HeB/FeJ mouse strain which is commonly referred to as the Kramnik mouse. This is an 
immunocompetent strain that has a mutation of the intracellular pathogen resistance 1 (Ipr1) 
gene (53) of the super susceptibility to tuberculosis 1 (sst-1) locus (52). The sst-1 mutation is 
mostly lung specific, hence upon aerosolized Mtb Erdman (100 CFU to 2 x104 CFU), organized 
caseous hypoxic lung granulomas develop (Figure 8).  
 
Figure8. Haematoxylin and eosin Tuberculosis granuloma tissue sections from C3HeB/FeJ mice (Source: 
Lenaerts/Barry/Dartois, 2015) 
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Figure9. Hematoxylin and eosin Tuberculosis granuloma tissue sections from TNF-α and IFN-g blocked 
Nos2-/- mouse (Source: Reece/Kaufmann, 2010) 
 
Even though granuloma pathology similar to that observed in humans develops, one limitation 
is that the immune system is still murine. Therefore, these mouse models are unable to 
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1.3 Immune response to TB 
Although animal models have certain limitations, they have provided information on the 
pathology of TB and on major cellular-molecular mechanisms of the immune response to TB 
(55). Some of these mechanisms have been confirmed in studies of rare human genetic 
conditions (56), on human clinical samples and from HIV- associated TB. In relation to the 
pathology of the disease, using a reductionist approach, these immune mechanisms can be 
divided into three stages (82).  
 
 
Figure10. Schematic depiction of the first three stages of the immune process in Mtb infection and 
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First stage  
Commencing from the 1920s, Florence Sabin and her colleagues determined that pulmonary 
alveolar macrophages were the primary immune cell that phagocytozes Mtb upon inhalation in 
rabbits (57). Phagocytosis is initiated by Mtb pathogen- associated molecular patterns (PAMPs) 
such as lipomannan (LM), mannose-capped lipoarabinomannan (ManLam) and phosphatidyl-
myo-inositol mannosides (PIMs) engaging a gamut of surface macrophage pattern recognition 
receptors (PRRs). PRRs consist of Toll like receptors (TLRs), complement receptors (CRs), 
mannose receptors (MRs), scavenger receptors (SRs), dectin, mincle and dendritic cell (DCs)-
specific intracellular adhesion molecule-3-Grabbing non-integrin (DC-SIGN) (58). A specific 
example of PAMPs-PRRs interaction is LM binding on TLR2-TLR1 heterodimers (59). Cholesterol 
serves as an anchor that promotes interactions between mycobacterial PAMPs and surface PRRs 
(60). PAMPs and surface PRRs interactions initiates the first steps leading to the intracellular 
killing of the bacteria, intracellular signaling cascade and cytokine/chemokine production by 
alveolar macrophages. The importance of specific TLRs has been shown in studies such as those 
conducted in TLR 2- deficient mice (61) and further confirmed in patients with polymorphisms in 
TLR2 (62). Both species, exhibited increased susceptibility to TB.  
The secondary cell types that phagocytize Mtb upon inhalation are airway epithelial cells (AECs) 
and alveolar Type II pneumocytes (Figure 10b). These cell types in conjunction with Mtb 
infected alveolar macrophages produce cytokines and chemokines that affect the cellular 
microenvironment; leading to an influx of monocytes, macrophages, DCs and neutrophils from 
neighboring capillaries (63, 71). First stage cytokines that include TNF-α, IFN-γ, IL-1α, IL-1β and 
IL-18, are produced concurrently with first stage chemokines such as chemokine (C-C motif) 
ligand 2 (CCL2), CCL5, C-X-C motif chemokine 5 (CXCL5) and CXCL8. Nouailles G. and colleagues 
from the Kaufmann laboratory observed that upon TLR-2 ligation AECs, secrete CXCL-5 that 
interacts with chemokine receptor 2 (CCR2) which prompts the recruitment of neutrophils in 
Mtb infected mice (72). In another study, patients from northern Spain that had CCL5 
polymorphisms were linked to susceptibility to TB (73). These two studies and others (71) lend 
support to the importance of various chemokines in the early TB stage working in tandem with 
early stage cytokines. 
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TNF-α in particular, is a key cytokine necessary for controlling Mtb infection in phagocytic cells 
(78). The importance of TNF-α to Mtb control, was also demonstrated in rheumatoid arthritis 
and Crohn’s disease patients that developed reactivated TB upon anti-TNF treatment (64). TNF-
α works in concert with IFN-γ activated macrophages, thus launching the mechanisms required 
to INHIBIT Mtb as shown by Flesch IE and colleagues from the Kaufmann Laboratory (65). The 
importance of IFN-γ in humans in controlling mycobacterial infection has been confirmed in 
studies examining children with mutations in interferon-γ-receptor gene. These children had a 
greater susceptibility to mycobacterial infections (66). 
Some mechanisms used by activated macrophages to destroy Mtb at this stage are; generation 
of reactive oxygen intermediates (ROI), generation of reactive nitrogen intermediates (RNI), 
acidification of phagosomes, secretion of lysosomal enzymes and production of defensins (38). 
Almost all of the above mechanisms mentioned have been confirmed in human TB studies, but 
the role of iNOS, nitrogen oxide (NO) and RNI is still controversial (68). Murine TB research (67) 
and Zebrafish M. marinium research (77), supports a protective role for iNOS/NO whereas in 
human TB research no clear role has been assigned. What is definitely known is that firstly, 
human peripheral blood monocytes produce NO upon Mtb infection (69); secondly, iNOS 
expression has been detected on active TB granulomatous tissue (70) and lastly, alveolar 
macrophages from active TB patients have a higher level of iNOS protein expression compared 
to healthy donors (71). 
In this first stage, some Mtb does escape macrophage killing mechanisms by hindering the 
fusion between the phagosome and lysosome (74), and by the use of protein secretion systems.  
Mtb protein secretion systems located in RD1 are commonly referred to as early secreted 
antigen 6 kilodaltons (ESAT-6) secretion system (ESX). ESAT-6 in juxtaposition with CFP-10 
deliver virulence factors into host macrophages in order to further prevent the bacteria from 
being destroyed leading to necrotic death of the macrophages (76). In addition, RD1 acts on 
neighboring epithelial cells leading to the expression of matrix metalloproteinase 9 (MMP-9) in 
zebrafish. While in humans, it is MMP-1 that drives TB immunopathology (134). This causes 
more cytokines (such as IL-27 and IFN-β) and chemokines (such as CCL3 and CCL4) to be 
produced, prompting the recruitment of more phagocytic cells of the innate immune system 
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such as parenchymal lung macrophages, alveolar DCs, parenchymal DCs and neutrophils to take 
up evaded bacteria. This cytokine/chemokine storm and subsequent innate cell migration has 
also been observed in in vivo studies of infected rabbits (75) three hours post infection with Mtb 
(63, 71) (Figure 10b).  
Some of the alveolar DCs, parenchymal DCs, inflammatory monocytes, and neutrophils carry 
bacilli into the lung parenchyma generating a primary inflammatory focus known as the Ghon 
complex. Simultaneously, other alveolar DCs and parenchymal DCs carry whole bacteria to the 
draining thoracic lypmhnodes leading to the second stage of the immune process. These DCs 
also collect neutrophil Mtb apoptotic bodies which permit them to migrate faster to the 
lymphnodes compared to DCs that have phagocytyzed whole bacteria (110). The time frame for 
this first stage has been estimated to be about 8-10 days in mice and guinea pigs (79, 86), which 
is quite long compared to the approximately 20 hours it takes for influenza virus to be mostly 
killed and transported to the lymph nodes to kick off the second phase of the immune response 
(55). In humans, the closest anatomical confirmation of the first stage is from studies that 
showed that viable bacilli are present in apparently healthy lung acquired from autopsies (84). It 
is also estimated that, the time between infection and induction of the Ghon complex in 
humans is between 2 and 8 weeks (80). 
Second stage  
DCs are the most efficient antigen presenting cells (APCs), hence upon activation, T cells 
proliferate and differentiate into various types of effector T cells (87). DCs are quite 
heterogeneous, thus in the second stage, some DCs carry whole bacilli into the draining 
lymphnode consequently infecting the lymphnode itself. Simultaneously, other types of 
migratory DCs that are carrying bacilli undergo apoptosis and the mycobacterial antigenic 
peptides are released and picked up by uninfected activated lymph node resident DCs (Figure 
10c). The resident DCs present these Mtb antigens to naive T cells in the lymphnodes (81, 85). 
These antigens are presented to T cells via major histocompatibility class I (MHC-I), MHC-II and 
CD-1 presentation. MHC I molecules interact with CD8 T cells, MHC II molecules interact with 
CD4 T cells and lipids interact with the CD1 reactive T cell family, respectively (87). DCs 
trafficking and migration is prompted by chemokines such as CCL19, 20 and 21 in association 
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with chemokine receptors such as CCR6 and CCR7 (95). Increased expression of adhesion 
molecules such as lymphocyte function-associated antigen 1 (LFA-1), also promotes DC 
migration into the draining lymphnode upon TB infection (96).  
Recent functional homology studies have led to the correlation between human and murine DCs 
(97). Essentially, cluster of differentiation 103+ (CD103+) DCs in mice, are homologues to CD141 
high (CD141hi) DCs in humans. In mice, CD103+ DCs are the migratory DCs (98, 99) that interact 
with lymphnode resident CD8+ DCs (Humans: CD141+ DCs), CD4+ DCs (Humans: CD1c+ DCs) and 
plasmacytoid DCs (Humans: pDC). In human TB, Lozza L. and colleagues from the Kaufmann 
laboratory examined lymphnode tissue sections from TB patients, and observed that myeloid 
CD11c+ DCs, pDCs and CD141hi DCs were in close contact with CD3+ T cells and CD20+ B cells 
(100). Migratory DCs, resident DCs and naïve lymphocyte contact is important in order to 
initiate an adaptive response. The importance of this communication is observed in studies 
where mice have been depleted of DCs (101) and in humans with genetic DC deficiencies (102). 
In mice, this depletion resulted in a significant increase in bacterial loads in the lungs and 
spleens due to an inability to mount an efficient CD4 T cell response, while in humans, BCG-osis 
and susceptibility to Mtb kansasii was observed (REF). 
In the pre-anibiotic era, patients that suffered from lymphnode TB particularly cervical 
lymphnode TB (scrofula) were quite common (91, 94). Lymphnode infection has been proven by 
retrieving culturable bacteria and by pathological analysis of lymphnodes in murine TB (88), 
guinea pig TB (89), cattle TB (49) and NHP TB (90). Further evidence of lymphnode involvement 
in TB has been observed in NHPs (92) and latent TB (93) via FDG PET-CT. Increased inflammatory 
and immunological activity correlating with increased FDG uptake in the lymphnodes was 
observed. Currently, more research is being undertaken to understand the role of lymphnodes, 
lymphnode architecture, the lymphatics, lymphoid organs such as the spleen and their 
associated cells in TB control and dissemination (103, 228). 
In mice, the time frame for the second stage is approximately 11-14 days post aerosol infection 
while in humans measurable adaptive immune responses appear approximately 42 days after 
Mtb exposure (79). Lung homing of the effector T cells occurs under the influence of 
chemokines and mediators which sets up the third stage of the immune process. 
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Third stage  
Effector T cells originating in the draining lymphnodes migrate to the lungs through the efferent 
lymphatics and the pulmonary capillaries to the site of inflammation under the influence of 
chemokines such as CXCL13, CC19 and CCL21 (106). T cell migration through the lung 
parenchyma is also aided by the expression of CXCR3 and CXCR5 (107,108) and adhesion factors 
such as intercellular adhesion molecule 1 (ICAM-1) (104) (Figure 10c). These chemokines also 
lead to the further recruitment of a new set of natural killer (NK) cells, CD4+, CD8+, gamma delta 
T cells, CD1-restricted T cells and B cells. In the meantime, a series of third stage cytokines are 
released in the microenvironment. These cytokines drive the development, differentiation and 
functional capabilities of immune cells that are part of the bridge between the innate and the 
adaptive response. Hence in this stage; lymhnode effector cells, lung parenchyma effector cells 
and vascular effector cells in concert with innate cells are involved in a balancing act between 
pro-inflammatory and anti-inflammatory effects which can be illustrated as a protective state 
versus a pathological state (111). 
In this stage, some of the recently recruited innate cells are newly infected with Mtb 
consequently secreting cytokines such as IL6, IL-8, IL-12 and 1L-23. The importance of the IL-
12/IL-23 axis and its associated components in controlling Mtb has been confirmed in patients 
with Mendelian susceptibility to mycobacterial disease (MSMD). MSMD patients have 
mutations in genes encoding for IFNγ receptor 1 (IFNGR1), IFNγ receptor 2 (IFNGR2), Signal 
Transducers and Activators of Transcription 1 (STAT1), the p40 subunit of IL-12 and IL-23, IL-12 
receptor β1 (IL12RB1), nuclear factor-κB (NF-κB) essential modulator (NEMO), Cytochrome b-
245 (CYBB) and interferon regulatory factor 8 (IRF8). All these mutations have effects on 
mononuclear phagocyte subgroups, hence providing a link on the means by which 
mononuclears cells progress from tuberculous pneumonia to the classical granuloma structure 
at the site of the infection (109) (Figure 10d ).  
Simultaneously, CD4 T cell subtypes observed in this stage are T-helper 1 (Th1) cells, Th2, Th17, 
and regulatory T cells (T regs) (105). Naïve CD4 T cells upon stimulation by IL-12 and IFN-g 
differentiate into Th1 cells. Th1 cells are responsible for the production of cytokines such as 
TNF-a, IFN-g and IL-2. Th1 cells that simultaneously produce these three cytokines are termed 
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polyfunctional T cells. These polyfuntional T cells are involved in a coordinated effort with Th17 
cells to act upon intracellular pathogens such as Mtb (114). Th17 cells are generated when 
transforming growth factor-beta 1 (TGF-b1), IL-6 and IL-21 act on naïve CD4 T cells. Th17 cells 
produce cytokines such as IL-17, 21 and 22. In murine TB, it has been observed that lung IL-17 is 
mostly produced by gamma delta (gdTs) T cells (112) and that an IL-17 knockout mouse strain 
upon infection with a hypervirulent Mtb was unable to control the disease in comparison to a 
less virulent strain. In this study, it was observed that poor recruitment of T cells to the lung 
contributed to the inability of controlling the infection (113). In Human TB or NHP TB, most IL-17 
studies have been performed on peripheral blood lymphocytes (PBMCs) or bronchoalveolar 
lavage whence, a greater number of Th17 cells were found in latent TB samples (114). In 
addition, in latent TB samples, gdTs in particular Vg2Vd2 T cells which exists only in primates 
and in humans are activated by Mtb (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP) 
phosphoantigen and produce more IL-17 and IL-22 in comparison to active TB samples (115). 
This information thus supports the role of Th1, Th17 and gdTs as falling in the protective arm of 
the immune response.  
The pro-inflammatory responses (protective state) generated by Th1, Th17, gdTs and pro-
inflammatory innate immune cells cause a great deal of tissue damage (pathological state) in 
their quest to reduce the increasing bacteria numbers. Therefore, cytokines such as IL-4 and IL-2 
act on naïve CD4 T cells to differentiate into Th2 cells, while TGF-b and IL-2 cause differentiation 
into T regs (105). Th2 cells, T regs and anti-inflammatory innate immune cells in a synchronized 
effort produce anti-inflammatory cytokines such as IL-4, IL-5, IL-10, IL-13 and TGF-b in order to 
resolve the initial tissue damage (116).  However, efforts to resolve this tissue damage have 
been observed to contribute to reduced TB control in other words an immune suppressive state 
is brought about. This is carried out by T regs expressing intracellular transcription factor FoxP3 
that secrete IL-10 which suppresses macrophage activation therefore reducing the macrophages 
ability to kill Mtb (117). This also leads to; reduced antigen presenting competence, reduced IL-
1a, IL-12 and TNF-a production by innate cells, and reduced CD4+ T cell and CD8+ T cell activation 
and proliferation (117). These observations were reported by Kursar M. and colleagues from the 
Kaufmann laboratory and other groups using the experimental mouse model for TB (118, 135). 
In human TB, some studies report that there is an increase of T regs in the blood and lung of 
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active TB patients (119) giving credence to T regs involvement in immune suppression while 
other studies report no increase of T regs in active TB (120). In NHP TB, animals that had a 
significantly higher number of T regs in the blood prior to and during early infection developed 
latent TB (121). In this study, it was also observed that both active and latent TB animals had 
decreased number of T regs in the blood later during the infection and T regs were observed in 
the lymphocyte cuff of the lung granuloma. Collectively, these observations support the fact 
that T regs have different effects on infection outcome in regards to disease status. 
The main role of CD4+ T cells is to ‘help’ or augment the cytotoxic and humroral branches of the 
adaptive immune response. CD8+ cytolytic T cells (CTLs) and NK cells directly kill Mtb infected 
innate cells by the use of cytotoxic molecules such as perforin, granzymes and granulysin (124). 
Muller I. and colleagues from the Kaufmann laboratory and other groups have established a 
general protective role by CD8 T cells in murine TB (122, 169). This role has also been confirmed 
in NHP TB (123). Furthermore, in murine TB the antimicrobial role of CD8 perforin and granzyme 
(169), but not of granulysin has also been established. This is because; granulysin is only 
produced by NHP and human CTLs (125). Additionally, a more human specific function of CD8 T 
cells to TB is possible as CD8 T cells also include Vg2Vd2 T cells, Vα7.2 mucosal associated 
invariant T cells (MAITs) and lipid specific CD1 T cells (124). In humans and NHPs, the CD1 family 
consists of CD1a, b, c, d and e; in rabbits and guinea pigs it consist of  CD1a, b and c; in cattle it is 
made up of CD1a, b, d and e whereas mice have only CD1d and zebrafish have none (126). 
Taking in account the differences in the CD1 family across the various experimental models and 
in humans, there is evidence that CD8-CD1 T cell activation and CD4-CD1 T cell activation by 
mycobacterial lipids is part of the protective branch against TB. 
Even though the bulk of the immune response to TB in the third stage is made up of cell 
mediated immune mechanisms, humoral immunity is slowly being built up. B cells are the main 
components of humoral immunity and their main function upon activation is to proliferate and 
differentiate into plasma cells. Plasma cells produce antibodies that recognize and neutralize 
extracellular pathogens (128). Antibody classes are IgA found in mucosal areas such as the 
respiratory tract, IgD, IgE, IgG and IgM (128). B cells also act as APCs so they can activate 
traditional T cells and non-traditional T cells as some human B cells express CD1c and CD1d 
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(127). Experimental TB studies that focus on the role of B cells and antibodies in the mouse 
show conflicting results (136). One study that used mice that have B cells but lack secretory 
immunoglobin, showed that these mice, were more susceptible to TB in comparison to wild 
type mice due to an increase macrophage production of IL-10, IL-6 and GMCSF as the disease 
progressed (137). This suggests that B cells play a role in the last steps of the disease as the 
bacteria is gearing up for transmission. In another study that used mice that lacked B cells and 
were reconstituted with B cells from tuberculosis infected wild type mice; these mice controlled 
TB upon infection compared to their B cell deficient counterparts (138). This control was 
achieved by limiting neutrophil infiltration suggesting that B cells aid in controlling the disease 
during the initial infection. A murine TB study, in line with what has been observed in human TB 
studies showed that B cells were present as aggregates with T cells in the lung in a manner 
reminiscent of lymph node germinal centers (131). These lymphoid follicular like structures are 
created under the influence of chemokines such as CXCL13, CC19 and CCL21. Ulrichs T and 
colleagues from the Kaufmann Laboratory characterized these B cell aggregates in lung tissue 
from active TB patients (130). In addition to B cell aggregates, B cell clusters and antibodies are 
located in the lymphocyte cuff of the lung granuloma in NHP and human TB (139). B cells and 
antibodies have not being assigned a clear role in TB, but their location suggests that B cells 
have the opportunity to directly interact with T cells and innate cells thus having pro and anti-
inflammatory functions (129).  
In mice, the time frame for the third stage is approximately 28-30 days post aerosol infection 
while in humans the time frame of the third stage is variable (1 to 5 years post initial infection) 
as this is connected to each person’s individual status (141).  
Quality of the Human Lung Immune response to Tuberculosis 
The quality of the immune response in all three stages depends on an individual’s genetics, their 
age, their health status, their nutritional status, their exposure rate to TB, their vaccination 
status and the Mtb strain they encounter. Specifically, events that occur in the first stage of the 
immune response could have a cascade effect on the next two stages (142). These events lead 
to early clearance or a range of infection/pathology (133, 140). 
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In the first stage; it is true that alveolar macrophages, AECs and alveolar Type II pneumocytes 
are the first phagocytes, but neutrophils are the largest infected cell type in the airways of 
active TB patients (132). In an immunocompetent individual that has an optimal nutritional 
status, optimal health status and low exposure to TB, the neutrophils aid in early clearance of 
Mtb. Early clearance is defined as the successful eradication of Mtb before an adaptive response 
develops (133).  Early clearance occurs due to the neutrophils deploying reactive oxygen species 
(ROS) (143), secreting antimicrobial peptides such as cathelicicdin (145) and possibly via 
neutrophil extracellular traps (NETS) (144). Early clearance is also established when apoptotic 
cell death instead of necrotic cell death occurs in the alveolar macrophages and the neutrophils 
(146). Toxic metals such as zinc are also involved in early clearance by directly acting on Mtb in 
macrophages (147).  
In an immunocrompromised individual that has a sub-optimal nutritional status, sub-optimal 
health status and high exposure to virulent TB, neutrophils actually promote Mtb growth. 
Virulent Mtb can survive human neutrophilic ROS by inducing necrotic cell death (148) via the 
enhanced intracellular survival (eis) gene (149) and the NADH-quinone oxidoreductase subunit 
G (nuoG) gene (148). Other Mtb virulent factors that inhibit apoptotic cell death are 
serine/threonine kinase Pkne protein (150) and the RV3364c protein (151). Virulent Mtb also 
induces the production of eicosanoid lipoxin A4 (LXA4) in macrophages, which leads to necrotic 
cell death while inhibiting prostaglandin E2 (PGE2) which is linked to apoptotic cell death and 
subsequently clearance (152). In the case of toxic metals such as Zinc, Mtb up regulates the 
gene ctpC to control bacterial levels of this metal thus mitigating its effect (147). 
In the situation whence innate cell clearance is not optimal; as previously mentioned in stages 
two and three, there is a dynamic recruitment of a vast number of innate and adaptive cells to 
the lung. In this vast number of recruited adaptive cells, approximately 1-30% are Mtb antigen 
specific T cells (153, 154). It should be noted that this frequency, depends on which part of the 
NHP or human lung has been sampled, which antigens (PPD, ESAT6/CFP10, antigen 85 or 
TB10.4) have been used for restimulation and if tetramers have been employed for more 
specific detection (155).  
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In an immunocompetent individual, with a sub-optimal nutritional status, sub-optimal health 
status and high exposure to virulent TB, the Mtb specific T cell response is higher in the lung 
thus preventing active disease from occurring and the bacterium avoids further elimination 
(latent/subclinical infection) (156). Continuous survival of the bacteria is also possible via the 
induction of the dormancy survival regulator (DosR) regulon, composed of 48 co-regulated 
genes (38, 157). The importance of antigenic specific T cells for Mtb survival is exhibited by the 
fact that the most conserved part of the Mtb genome is associated with human T cell epitopes 
(158). CD4+ T cells in particular, have a clear role in Mtb confinement in latent/subclinical 
granulomas, as it has been shown that direct contact of CD4+ T cells with Mtb infected 
phagocyte sub groups is necessary to contain the infection in murine TB (159). Furthermore, 
CD4+ T cell depleted NHPs suffer from exacerbated disease (160, 161) and SIV infection of 
latently TB infected NHPs causes reactivated TB (162). This gains clinical significance on 
examining HIV+ patients who are more susceptible to tuberculosis and are more likely to have 
disseminated TB with disorganized granulomas (163). 
In an immunocrompromised individual; such as patients undergoing anti TNFα therapy, the 
immune response cannot contain the infection leading to liquefication and caseous necrotic 
granuloma formation (164). The extra layer of neutrophils, epithelioid macrophages and foamy 
macrophages prevent Mtb specific T cells from migrating to the priority sites and directly acting 
on the necessary innate cells (165). Further impairment of antigen specific T cell function, is part 
of the sequence that pushes caseous granulomas into cavitary TB (166, 167). Caseating 
granulomas are also associated with the typical symptoms of active disease such as a productive 
cough, fever and weight loss. Other forms of tuberculosis that can occur in an 
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2 Humanized mice 
 2.1 History of Humanized mouse 
Humanization is defined as endowing human characteristics or attributes to an object or animal. 
In biological research, humanization of mice can either be cellular-tissue humanization or 
genetic humanization. Genetic humanization involves replacing mouse genes with the 
corresponding human gene (170) while cellular-tissue humanization involves the 
transplantation of human cells and tissues (171). There were three major developments that 
occurred in the 1980s to 1990s which led to the reduction of certain barriers to cellular-tissue 
humanization (183). 
Firstly, in 1983, a spontaneous severe combined immunodeficiency mutation (SCID) was 
observed in CB17 mice (172). These mice were subsequently used to engraft human PBMCs and 
various human stem cells (173, 174). Engraftment occurred but at suboptimal levels due to 
certain limitations such as T and B cells reappearing while the mouse aged, high numbers of NK 
cells and sufficient mouse innate activity that circumvented the ability of human cells or tissues 
to engraft (Figure 11).  
 
Figure11. Timeline describing some significant advances in humanized mouse models (Source: 
Marsden/Zack, 2015) 
Secondly, the development of immunodeficient non-obese diabetic (NOD) SCID mice led to 
further reduction of murine NK cell, reduced immune cell activity and radiosensitivity leading to 
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a slight improvement of human engrafted rates (175). Concurrently, targeted mutations at the 
recombination-activation gene 1 (Rag1) and Rag 2 were also developed (176, 177). This led to 
lower numbers of murine T and B cells, but no radio sensitivity and high numbers of NK cells 
hence the human cell engraftment rates was still suboptimal. Thirdly, in 1995, mice with 
targeted mutations in the interleukin 2 receptor gamma chain (IL-2Rg) locus were generated 
(180, 181). The IL-2Rg chain is a major component of the receptors IL-2, IL-4, IL-7, IL-9, Il-15 and 









Figure12. Schematic depiction for receptors for gamma chain cytokines and thymic stromal 
lymphopoietin (Source: Rochman/Spolski/Leonard, 2009) 
These three major developments led to the generation of the BalbC Rag2 null IL-2R gamma null 
(BRG) mouse, the NOD SCID IL-2 receptor gamma null (NSG) mouse and the NOD Rag1 null IL-2 
receptor gamma null (NRG) mouse. These mouse strains have been observed to have up to a 
fivefold higher level of human CD34+ hematopoietic stem cell (HSCs) engraftment compared to 
the previously described mouse strains (178, 179) and are therefore being used as a platform to 
further investigate the human hematopoietic system. Details on the main variables to consider 
while generating a Human Immune System (HIS) mouse model listed in Table 2 and are 
summarized in the following paragraphs. 
Strain background NSG, NRG or BRG 
Age of the recipient Newborn, juvenile or adult 
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Source of human cells or tissue Fetal liver stem cells, cord blood stem cells, 
bone marrow, mobilized PBMCs 
Injection route Facial vein, intracardiac, intrahepatic, 
intrafemoral, intravenous , surgical graft 
Conditioning Irradiation 
Table2. Factors to consider in HIS mouse model generation 
Although the NSG, NRG and BRG mouse strains all have targeted mutations in the IL2r common 
gamma-chain, the NSG and the NRG mice develop higher levels of human engraftment due to 
the NOD background (184). In particular, the NOD signal regulatory protein alpha (SIRPa) 
recognizes human CD47 which allows NOD mouse macrophages to stop phagocytosis of human 
cells (185). Despite their profound immunodeficiency, these mice need a preparative regimen in 
order to permit engraftement of human HSCs. Sub lethal irradiation of these mice results in the 
depletion of murine HSCs thus creating space in the bone marrow and increased concentrations 
of chemokines such as stromal derative factor 1 (SDF-1). This pulls human stem cells into the 
bone marrow in a CXCR4 dependent manner (186). Furthermore, the HIS engraftment levels 
specifically  the human T cells, are higher in NSG newborns (1-2 days) compared to adults (5-
7weeks) due to the fact that newborn mice do not suffer from thymic dysplasia like the adults. 
This allows the human CD34+ cells to contribute to thymus organogenesis (184).  
HIS engraftment levels are also affected by the source of the CD34+ stem cells. Human fetal liver 
and umbilical cord blood HSCs delivered via intracardiac or intrahepatic injection to sublethaly 
irradiated newborn NSGs (Hu-HSC, figure 9) have a greater level and breadth of engraftment 
compared to HSCs generated from mobilizied adult blood or peripheral blood leukocytes (Hu-
PBL-SCID, figure 9) (187). Human fetal liver HSCs in general also confer higher engraftment rates 
compared to cord blood HSCs possibly due to the fact that fetal liver HSCs are more primitive 
progenitors with a greater repopulation capacity (188). Intracardiac, intrahepatic and facial vein 
injections are the preferred injection route for newborns while intrafemoral and intravenous 
are the preferred route for juveniles and adults. Another engraftment route for adults is by 
surgical graft of fragments of fetal liver and fetal thymus under the mouse kidney capsule 
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followed by the intravenous injection of human HSCs preferably from the same donor. These 
mice are termed bone marrow-liver-thymus (BLT) mice (Figure 13). 
 
Figure13. Overview of the major humanized mouse models used in hematopoietic and infectious 
disease research (Source: Marsden/Zack, 2015) 
 
Upon engraftment of CD34+ HSCs, the Hu-HSC mice also known as HIS mice have been observed 
to develop all lineages of human hematopoietic cells in the blood and other organs (Figure 14). 
These cells are the T cells, B cells, NK cells, DCs, monocytes/macrophages, granulocytes, 
erythrocytes, megakaryocytes and platelets (189). HIS mice in particular the HIS NSG mice, have 
been observed to have a sufficient pool of human HSCs greater than 10 weeks post engraftment 
in the bone marrow which aids in the maintenance of long term hematopoiesis (262). HIS NSG 
bone marrow has also been observed to be morphologically and phenotypically similar to 
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human bone marrow aspirates (263). Furthermore, the different human immune subsets that 
have been observed in various organs of the HIS NSG mice have been shown to share basic 
phenotypic and functional characteristics with cells obtained from human volunteers. These 
human immune cells are also present for greater than 9 months post-transplantation.  
The human myeloid cells in the HIS NSG mouse have been shown to phagocytize beads and 
pathogens. They also respond to cytokines and secrete cytokines via TLR2 and TLR4 (264, 265). 
Additionally, HIS NSG mice that have been engrafted as pups with HSCs from cord blood have 
been observed to have human myeloid cells that are phenotypically immature with a reduced 
ability to stimulate T cells in comparison to HIS NSG mice that have been engrafted as adults 
with HSCs from human adult peripheral mobilized blood (266). This immature phenotype with 
limited T cell stimulating capability in neonate engrafted HIS NSG mice is thus similar to the 
human newborn innate immune system (267). The human adaptive system that develops in 
neonate engrafted HIS NSG mice is also similar to a human newborns’ adaptive immune system 
(268). HIS NSG mice have conventional and non-conventional T cells that develop with a diverse 
T-cell repertoire (269, 270), but have lower functional capabilities in comparison to human adult 
T cells (271). The B cells that develop are mostly CD5+ B cells which are classified as immature B 
cells and have a reduced ability to respond to antigens (271, 272), but these B cells do have a 
diverse B-cell repertoire similar to what has been observed in humans (273, 274). 
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Figure 14: Schematic of current model of lineage determination in the Human hematopoietic hierarchy 
(Source: Doulatov/Notta/Laurenti/Dick, 2012) 
HIS mice have some limitations as they are a chimera of human and mouse. Some of these 
limitations are; most of the mouse cytokines and growth factors cannot act on the human 
immune cells causing sub-optimal development and function; the endothelium, epithelium and 
stroma are still murine which could influence interactions with the human immune cells; the 
mouse innate system is albeit sub-optimal in function, but it is still present; and there is no 
human leukocyte antigen (HLA) so there is poor communication between human APCs and 
human T cells that develop (190). Poor communication between human immune cells also leads 
to a suboptimal humoral immune response with lower levels of antibody production in 
comparison to what is observed in an immune-dominant situation. Immunoglobulin class 
switching is also compromised. Since murine T cells and B cells are absent, there is no scaffold 
for proper lymphnode development and the accompanying germinal centers (190, 275). Despite 
these limitations, HIS mice have been used in various research fields such as basic immunology, 
tumor immunology, therapeutic development and infectious diseases (191).  
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2.2 Humanized mice and Infectious disease 
Some of the infectious diseases studies that have used the HIS NSG mice to investigate the 
pathology and immune response using a more natural route of infection are listed below (192). 
Pathogen category Pathogen Reference 
Virus HIV 207, 208, 209 
 Epstein Barr  204, 205, 206 
 Hepatitis C  203 
 Dengue  200, 201, 202 
 Ebola 193 
Protozoan Plasmodium falciparum 194, 259 
 Leishmania 195 
Bacteria Salmonella typhi 196 
 Sepsis 197, 198, 199 
 Staphylococcus aureus 276, 277 
 Borrelia hermsii 278 
Table3. HIS mouse Infectious disease studies 
2.3 Rationale for undertaking this thesis project 
There are more than 80 differences between the mouse and human immune system. These 
differences do have a certain impact on translating research carried out in mice to humans. 
These differences arose as the two species evolutionarily diverged 65 to 75 million years ago; in 
respect to their living environment, body size, day-night cycle, pathogens encountered and 
lifespan (210). These differences include; differential expression of TLR2/3/9/10, different 
antibody isotypes and different FCR receptors. As previously mentioned in this thesis 
introduction, there are differences in CD1 genes between mice and humans. There are also 
human specific classifications of certain cells such as gamma delta T cells, CD8 granulysin T cells, 
CD8 MAIT cells and neutrophil defensins. Broader differences between mice and humans are 
exhibited in physiological/anatomical sites such as the blood whence humans are neutrophilic 
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rich (50-70% neutrophils, 30-50% lymphocytes) while mouse blood is lymphocytic rich (10-25% 
neutrophils, 75-90% lymphocytes).  
A 2013 comparative biology study examined the gene expression of serially drawn white blood 
cells in trauma, burns and endotoximia in humans and mice (211). The study conclusion stated 
that the inflammatory gene expression patterns of the human groups correlated more with 
each other than with the associated mouse group. A competitor group using the same data set 
in 2015 but with different computational tools stated in their conclusion that the inflammatory 
genomic responses of humans and mice correlate with each other in their respective groups 
(212). These studies have spurred research that aims to harmonize or delineate human-mouse 
differences and their impact on immunology, inflammation, infectious disease and drug 
therapy. There have also being calls for properly designed and analyzed animal experiments 
(213); in consideration of the fact that 90% of the animal model based drug research that enter 
clinical trials fail (214).  
An example of a failed trial that had dangerous consequences is the hepatitis B drug fialuridine. 
Fialuridine was administered to 15 patients in a phase 2 trial after undergoing toxicology testing 
in mice. Five of the patients died while two required liver transplants (215). A retrospective 
study done in immudeficient mice with partially destroyed mouse liver cells and repopulated 
with human liver cells showed these mice died after receiving fialuridine (218). The Hu-
hepatocyte (Hu-Hep) mice exhibited pathology similar to that of the human patients that died. 
The cause of death was linked to the drug being taken up by a transporter expressed in human 
mitochondria, but not in mouse mitochondria. Another example is the previously mentioned 
antibiotic linezolid. This antibiotic had limited activity in mouse studies (216, 217) and was 
subsequently sidelined until clinicians pushed for the drug to be administered to some MDR TB 
and XDR-TB patients (29, 30 and 230). The failure of some TB drug studies could be linked to the 
fact that mouse TB granulomas are not organized in a stratified manner with various immune 
cells as exhibited in humans. This could have an effect on drug penetrance into the granuloma 
and the drugs mode of action in the diverse oxygen environments arising in various granulomas 
(231, 232). Hence the premise of my first thesis aim is to establish a HIS mouse model that 
develops granulomas reflective of human pathology. The fulfillment of this aim will provide the 
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groundwork to eventually establish a pre-clinical platform for TB drug therapy evaluation in the 
HIS mice. 
In order to supplement animal experimentation, there has been a marked improvement in the 
in vitro or ex vivo handling of human primary cells and human tissue. These include more 
controlled authentic cell lines (219), 3D cell culture (220), tissue explants cultures (221) and 
organ-on-a-chip (222). In addition to this, more physiological relevant methods such as culturing 
cells in hypoxic chambers (223) or using different stimulants to exhibit a range of human 
macrophages (224) are being employed. These systems do provide valuable information, but 
are limited as dynamic cell interactions are not fully recapitulated and there is a challenge in 
acquiring lung specific cells. As previously stated, human blood is neutrophilic rich, whereas the 
human bronchoalveolar compartment in a “naïve” state is made of 90-95% macrophages, 5-10% 
lymphocytes and less than 1% neutrophils (225). In addition, human alveolar macrophages and 
alveolar dendritic cells are different from blood monocytes and dendritic cells on the 
transcriptomic level (97). This leads to differences in their interactions with the same pathogen. 
In regards to TB, human alveolar macrophages infected with Mtb in vitro produce more TNF-α, 
IFN-g, IL-12 and chemokines than blood monocytes (226, 227). Furthermore, human alveolar 
macrophages have greater phagocytic capabilities than peripheral blood–derived macrophages 
(227, 229). Hence the premise of my second thesis aim is to perform a comprehensive analysis 
of human in vivo immune responses to TB at the site of infection- the lung, as the disease 
progresses.  
A great number of the major infectious pathogens exhibit host restriction. Host restriction or 
specificity is defined as the ability to colonize or infect a host (233). Host specificity arises due to 
certain molecular factors or receptors that are required by the virus, bacteria or parasite to 
invade a host (234). As human specific pathogens cause the greatest disease burden worldwide, 
alternative species have been used in order to understand immunopathology and generate 
drugs and vaccines. These alternatives are illustrated by the use of SIV or SHIV instead of HIV in 
NHPs, Plasmodium berghei instead of Plasmodium falciparum in mice and Salmonella 
typhimurium instead of Salmonella typhi in mice. Other alternatives include the murinazation of 
the Hepatis C virus (235) and the murinazation of the bacteria Listeria monocytogenes in order 
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to cause oral listeriosis (236). For TB, options include as previously mentioned, M. marinium 
instead of Mtb in zebrafish, M. bovis instead of Mtb in cattle and BCG in human in vitro systems. 
Mtb does infect a range of vertebrates as shown by Robert Koch and various scientists till 
present date, but only humans are naturally infected with Mtb as modern humans coevolved 
with Mtb 70,000 years ago. Therefore, Mtb has shaped the human immune system and 
concurrently the human immune system has shaped Mtb (237). Hence the supportive premise 
of my second thesis aim is to perform a simultaneous analysis of the host and bacteria as the 
disease progresses. Fulfilling this aim will provide a framework to understand other human 
specific bacteria such as Neisseria gonorrhoeae, Neisseria meningitides and Mycobacterium 
leprae and human specific viral-bacteria co infections such as HIV-TB. 
As previously mentioned, a good number of the HIS mouse studies have been done for viruses 
(191, 192). Viruses and bacteria trigger different immune responses and subsequently different 
killing mechanisms and pathology even if they infect the same site such as the lung. For 
instance, in a Hu-PBL BRG mouse aerosol influenza study, the mice developed signs of influenza 
associated pneumonia (238, 239) which is pathologically different from TB granulomas. HIS 
mouse studies done that are done with bacteria such as Salmonella typhi (196, 240), sepsis (197, 
198, and 199) and Borelia (278) exhibited some of the specific disease associated clinical 
features seen in human patients. For Borelia, this was recurrent bacteremia which is associated 
with relapsing fever and for sepsis this was a cytokine storm. These studies further support my 
first thesis aim of establishing a HIS mouse model that develops human TB clinical features and 
TB pathology. 
Recently, there have been three groups that used the NSG mouse as a platform to investigate 
mycobacteria. Heuts and colleagues engrafted newborn NSG mice with cord blood derived stem 
cells (241), whereas, Calderon and colleagues (242) and Lee and colleagues (243) generated BLT 
NSG mice. Heuts et al administered BCG intravenously, and they observed granulomas 
containing human cells in the liver. Lee et al administered BCG via the intra tracheal route and 
they observed lung lesions containing human cells. Both these studies did not exhibit caseous 
necrotic lung granulomas as BCG lacks RD1 a key virulence factor of TB that directs the 
macrophages to begin granuloma organization (76, 247). Heuts et al used an infection route 
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that gave pathology in the liver and not the lung which is the main site of infection in TB. 
Furthermore, there are some differences between Kupffer liver macrophages and lung alveolar 
macrophages which could influence the results observed (244, 245). Calderon et al administered 
intra nasally 250 CFU to 106 Mtb bacteria. In their study; at 6 weeks post infection, they did 
observe large caseous necrotic lung granulomas with a CD3+ T cell outer rim similar to that 
observed in active TB. The human infectious dose is estimated to be less than 10 bacilli (246); 
which is much lower than the traditionally administered dose used in various experimental 
models. Therefore the additional premise to my first thesis aim is to establish a Human Immune 
system (HIS) mouse model using a more natural dose and route of infection. 
Aims of this PhD project 
The main aims of this study are thus: 
 1) Establish a Human Immune system (HIS) mouse model that develops granulomas reflective 
of human pathology upon ultra-low dose aerosolized Mtb infection 
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Materials and Methods 
Ethics 
All animal experiments were conducted according to German animal protection law 
(Landesamtes für Gesundheit und Soziales Berlin G03070/12 and G0081/09). All human material 
received approval from Charite Medical hospital, Berlin.  
All protocols implemented are courtesy of the Kaufmann Lab Max Planck Institute of Infection 
Biology Berlin, Munz Lab University of Zurich, European core facilities and US core facilities. 
Statistical analysis   
Statistical analysis was performed using GraphPad Prism software for Windows. When two 
groups were compared, the following tests were used: unpaired or paired t-test (parametric 
analyses) or Mann-Whitney test or Wilcoxon Rank-Sum test (non-parametric analyses). When 
more than two groups were compared, one of the following tests was used: ANOVA (parametric 
analyses) or Kruksal-Walis test and Dunn’s post-test (non-parametric analyses). 
Preparation of Human stem cells  
Human fetal liver (15-22 weeks) was obtained from Advanced Bioscience Resources. The tissue 
was minced and treated with 2 mg/mL collagenase D (Cat #: 1088882001; Roche Diagnostics) in 
Hanks balanced salt solution with CaCl2/MgCl2 (Cat #: 24-020-117; Gibco) for 30 minutes at 
37oC in a 5% CO2 incubator followed by filtering through 70-μm nylon cell strainers (Cat #: 
352350; BD Biosciences). 30 ml of Hanks/collagenase liver cell slurry was carefully layered on 
15ml ficoll (Cat #: L6115; Biochrom) in a 50 ml falcon tube (Cat #: 62.547.254; Sarstedt) and 
centrifuged at 2000 rpm, room temperature (RT) for 30 minutes with no break. After 
centrifugation, the mono-nuclear cell layer (MNC) was collected using a 10 ml pipette (Cat #: 
86.1251.025; Sarstedt) and transferred into a fresh 50 ml tube. 25 ml of cold Phosphate Buffer 
solution (PBS) (Cat #: 10010023; Gibco) was added to the MNC and underwent centrifugation 
of 1200 rpm at 4oC for 10 minutes.  
The cell pellet was resuspended in 20 ml of MACS buffer that was composed of PBS, 2mM EDTA 
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(Cat #: 15575020; Life technologies), 0.5% bovine serum albumin (BSA) (Cat #: 130-091-376; 
Miltenyi Biotech) and underwent centrifugation of 1200 rpm at 4oC for 10 minutes. An aliquot 
was taken to determine cell numbers with Trypan blue solution (Cat #: 15250061; Life 
technologies) using a Neubaeur counting chamber and a light microscope. CD34+ human 
hematopoietic stem and progenitor cells (HSPCs) were isolated from the MNC using the direct 
CD34 MicroBead human ultrapure kit (Cat #: 130-100-453; Miltenyi Biotec). The MNC was 
resuspended in MACS buffer at 300ul for 108 MNC in a 15 ml falcon tube (Cat #:62.554.502; 
Sarstedt). 100ul of CD34 and 100ul FC block per 108 MNC was added. The cell bead mix was 
incubated for 30 minutes at 4oC. At the end of the incubation, 10 ml of MACS buffer was added 
to the cell bead mix and underwent centrifugation of 1200 rpm at 4oC for 5 minutes. The 
supernatant was decanted and the cell pellet was resuspended in 300 ul per 108 of MACS 
buffer. A MACS LS (Cat #: 130-042-401; Miltenyi Biotech) column was placed in a magnetic 
MACS separator (Cat #: 130-042-302; Miltenyi Biotech). The LS column was rinsed with 3 ml of 
MACS buffer and allowed to empty out by gravity flow. 3 ml of cell bead mix was applied to the 
column and allowed to empty out by gravity flow into a fresh 15 ml tube. The column was 
rinsed with two subsequent 3 ml MACS buffer washes.  
The column was removed from the separator and the CD34+ fraction was flushed out by using a 
plunger and 6 ml MACS buffer. The CD34+ fraction underwent centrifugation of 1200 rpm at 
4oC for 5 minutes and was reapplied on a fresh LS column in order to increase the purity as 
previously described. A 20ul aliquot of the CD34+ fraction was taken to determine cell numbers 
and purity via flow cytometric analysis. The CD34+ HPCs were frozen in StemMacs Cryo-Brew 
solution (Cat #: 130-109-558; Miltenyi Biotech) in Nalgene cryotubes first overnight at -80 oC in 
Nalgene freezing containers and then stored in liquid nitrogen at -178 to -150oC. 
Generation of Human Immune system mice 
NOD. Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice were obtained from The Jackson Laboratory (Cat #: 
005557) and were kept and bred under specific pathogen-free conditions at the Max Planck 
Institute of Infection Biology, Berlin (MPIIB). CD34+ HPCs frozen cryovials were submerged in a 
37oC water bath and were gently swirled back and forth until 90% of the cells were thawed. The 
CD34+ HPCs were gently decanted into 5ml of PBS and underwent centrifugation of 1200 rpm at 
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4oC for 5 minutes. The CD34+ HPCs were filtered over a 70-µm filter and resuspended in PBS. 
Cell viability and cell numbers were determined using Trypan blue and a light microscope. One- 
to three day-old NSG mice were irradiated with 100 cGy and injected intrahepatically (Hamilton 
glass syringe, Cat # 81001; Hamilton microneedle, Cat #: 7748-16) with 1-2 × 105 CD34+ HPCs in 
25ul of PBS 24 hours after irradiation. In specific experiments, some mice were injected with 
50ul of PBS as a control.  
Human immune reconstitution determination 
 Flow cytometry analysis 
100 to 200ul of blood was collected from the tail vein by tail cut and placed in a 1.5 ml tube that 
contained 100ul of heparin (Cat #: N65542.03; Ratiopharm). The heparinized blood underwent 
centrifugation of 3000 rpm at RT for 5 minutes. The plasma fraction was collected and placed in 
a fresh 1.5 ml tube. This plasma fraction was frozen at -20oC. The blood pellet was resuspended 
in 100ul of staining mix made of the components in the table below (Table 4). The blood pellet 
mixture was incubated at 4oC in the dark for 30 minutes. 1 ml of 1:10 diluted water BD 
biosciences Lysing fix buffer (Cat #: 349202) was added to blood pellet mixture and the sample 
was incubated for an additional 10 minutes at RT in the dark. At the end of the incubation 
period, the sample underwent centrifugation at 1700rpm for 5 minutes at 4oC. The supernatant 
was decanted and 100ul of PBS was added. The peripheral leucocytes were then analyzed by 
fluorescence-activated cell sorting (FACs) on a BD LSR II flow cytometer to check for the level of 
reconstitution of the human immune system. The gating strategy implemented and visualized 
using FlowJo software was done taking into account isotype stains and fluorescent minus one 
(FMO) stains. 
Ab FLUOROPHORE clone Catalog 
number 
Company 
Anti- human CD4 
Helper T cells 
A488 OKT4 317420 Biolegend 
Anti- human CD19 B 
cells 
PE  HIB19 302208 Biolegend 
Anti- human CD3 T cells PerCp  UCHT1 300428 Biolegend 




H130 304036 Biolegend 
Anti-mouse CD45  Alexa Fluor700 30-F11 103128 Biolegend  
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leukocytes 
Anti- human CD8 
Cytotoxic T cells 
Brilliant violet 
421 
SK-1 344748 Biolegend 
Mouse FC block clone 
2.4 G2 
None  93 101320 Biolegend 
Human FC block None None 422302 Biolegend 
Cell staining buffer None None  420201 Biolegend 
Table4. Peripheral blood FACS panel          
Infection with M. tuberculosis 
The M. tuberculosis strain H37Rv (Cat #: 27294; ATCC) was cultured in Middlebrook 7H9 broth 
(Cat #: 271310; BD biosciences) supplemented with 0.05% (v/v) Tween 80 (Cat #: P4780; Sigma 
Aldrich) and Middlebrook ADC Enrichment (Cat #: 211887; BD biosciences) until mid-log phase 
(OD 600 nm 0.6–0.8). Bacteria were harvested, resuspended in PBS, and frozen at –80°C until use. 
For aerosol infection, mice received a dose of approximately 15-30 CFU M. tuberculosis in the 
lung, using whole body aerosol exposure system (Glas-Col). Aerosol particles were generated 
using a three-jet Collison nebulizer (BGI Inc, Waltham MA) fitted with a fluid reservoir. Mtb 
aerosol particles were dispersed under positive pressure over unrestrained mice that were 
placed in a stainless steel mesh cage capable of holding up to 250 mice. All infected mice were 
kept under bio-safety level 3 and under specific pathogen-free conditions at the Max Planck 
Institute of Infection Biology, Berlin (MPIIB). 
Organ harvesting 
Mice were sacrificed at specific time points by cervical dislocation and the organs were 
aseptically removed. These organs were the blood, lung, spleen, liver, kidney, whole bone, 
lymph nodes, heart, brain and spine. These organs were processed for various analyses under 
bio-safety level 3 conditions and were transferred for further analyses under bio-safety level 2 
environment after Mtb inactivation. 
Cell isolation for bacterial burden enumeration 
Soft organs such as the lung, spleen, liver and kidney were directly homogenized in 1 ml PBS 
containing 0.05% Tween 80 (v/v). Bone marrow homogenates were obtained by flushing out 
snipped femur and tibiae by using an insulin syringe (Cat #: 34900232; BD biosciences) 
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containing 1 ml PBS 0.05% Tween 80 (v/v) and was pressed through a 70-µm cell strainer using 
the plunger from a 2 ml syringe (Cat #: 300186; BD biosciences). Homogenates were then 
diluted in PBS containing 0.05% v/v Tween 80 and plated onto Middlebrook 7H11 agar plates 
supplemented with Middlebrook OADC Enrichment (BD). Bacteria colonies were counted after 3 
to 4 weeks of incubation at 37°C and reported as the median Log CFU. 
Cell isolation for phenotypic analysis 
After aseptic removal, the lungs, spleen, femur and tibia were transferred to a 15ml tube 
containing 10ml of hypthermosol storage media (Cat #: 101102; Biolife solutions). Organs were 
subsequently processed in cold complete RPMI medium (cRPMI). Complete RPMI medium 
consisted of 500 ml RPMI medium 1640 (Cat #: 31870-025; Gibco), 5 ml of 200 mM L-glutamine 
(Cat #: M11-004; PAA), 5 ml of 1M HEPES (Cat #: S11-001; PAA) , 500ul of 50 mM β-
mercaptoethanol (Cat #: 31350-010; PAA), 50 ml of heat-inactivated fetal bovine serum (Cat #: 
10270-106; Gibco) and 5 ml of 10000 U/ml penicillin- 10000 μg/ml streptomycin solution (Cat #: 
P11-010; PAA). The medium was filtered through a 0.22-μm filter unit (Cat #: SCGPS05RE; 
Millipore).  
The lungs were transferred to a sterile petri dish containing 10 ml of a collagenase cRPMI 
mixture. This collagenase mixture consisted of collagenase IV (0.7mg/ml) (Cat #: C5138; Sigma 
Aldrich) and collagenase D (0.3mg/ml) dissolved in cRPMI. The lungs were minced with surgical 
scissors and treated in the collagenase mixture for 30 minutes at 37oC in a 5% CO2 incubator 
followed by mashing through 40-μm nylon cell strainers (Cat #: 352340; BD biosciences) with a 
sterile 2ml syringe plunger. The cell strainer was then washed with 10 ml of cRMPI and the cell 
mixture was transferred to a 50 ml falcon tube. The lung sample underwent centrifugation at 
1500rpm for 5 minutes at 4oC. The supernatant was decanted and the cell pellet was loosened 
by flicking the bottom of the tube. 2 ml of diluted red blood cell (RBC) lysis buffer (Cat #:420301; 
Biolegend) was added to the lung cell sample. The lung cell sample was incubated at RT for 2 
minutes. At the end of the incubation period, the lysing was quenched by adding 10ml of cRPMI. 
The lysed lung cell samples underwent centrifugation at 1300 rpm for 5 minutes at 4oC. The 
supernatant was decanted and the cell pellet was resuspended in 1ml of cRPMI and filtered 
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over a 30-μm cell filter (Cat #: 130-041-407; Miltenyi biotech). An additional 1ml of cRPMI was 
used to rinse the filter. The lung cell sample was stored at 4oC prior to further analysis.  
The spleen was transferred into a 70-µm cell strainer in a sterile petri dish and pushed through 
with a 5 ml syringe plunger in 1 ml of cRPMI. The cell strainer was washed with 9 ml cRPMI and 
transferred into a 15 ml tube.  
For the bone, each end of the femur and tibia was snipped in a sterile petri dish. An insulin 
syringe containing 500ul of cRPMI was used to flush out the femur. An additional 500ul cRPMI 
was used to flush out the tibia. The bone marrow was flushed unto a 70-µm cell strainer and 
pushed through using a 2 ml syringe plunger. The cell strainer was washed with 5 ml cRPMI and 
transferred into a 15 ml tube. The spleen and bone marrow samples underwent centrifugation 
at 1500rpm for 5 minutes at 4oC. The supernatant was decanted and the cell pellet was 
ressuspended in 2 ml of RBC lysis buffer at RT for 2 minutes. At the end of the incubation 
period, the lysing was quenched by adding 10ml of cRPMI.  
The lysed spleen and bone marrow samples underwent centrifugation at 1300 rpm for 5 
minutes at 4oC. The supernatant was decanted and the cell pellet was resuspended in 2 ml of 
cRPMI and filtered over a 70-μm cell filter (Cat #: 130-095-823; Miltenyi biotech). An additional 
3 ml of cRPMI was used to rinse the filter. The spleen and bone marrow samples were stored at 
4oC prior to further analysis.  
An aliquot from the lung, spleen and bone marrow was taken to determine cell numbers and 
cell viability with Trypan blue solution using a Neubaeur counting chamber and a light 
microscope. 
Cell phenotypic analysis by flow cytometry 
Lung cells, splenic cells and bone marrow cells in single cell suspension were incubated at room 
temperature in the dark for 15 minutes in antibodies specific for human and mouse cell surface 
markers in a 96 round bottom plate (Cat #: CLS3799; Corning Costar). Human and mouse FcR 
blocking reagents were added in order to optimize the fluorescent stain. Two different panels 
were used, one labeled innate (Table 5) and the other labeled adaptive (Table 6). At the end of 
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the incubation period, 100ul of PBS was added to each sample. The samples underwent 
centrifugation at 1200 rpm for 3 minutes at 4oC. The supernatant was decanted 4% 
paraformaldehyde (PFA) (Cat #: 158127; Sigma Aldrich) was added. The samples were incubated 
for 20 minutes at room temperature in the dark. At the end of the incubation period, 100ul of 
PBS was added to dilute to 2%PFA and incubated overnight at 4oC in the dark. The next day, the 
samples underwent centrifugation for 3mins at 1500rpm. The supernatant was discarded and 
the cells were resuspended in 100ul clean PBS and transferred to a fresh TB free 96 well plate. 
The leucocytes were then analyzed by fluorescence-activated cell sorting (FACs) on a BD FACS 
CANTO II. The gating strategy implemented and visualized using FlowJo software was done 
taking into account isotype stain and fluorescent minus one (FMO) stains.  
Ab FLUOROPHORE clone Catalog 
number 
Company 




H130 304036 Biolegend 
Anti-mouse CD45  
leukocytes 









Anti- human HLADR  PECF 594 G46-6 562304 BD 
Anti- human HLA-ABC  PERCP CY5.5 W6-32 311419 Biolegend 
Anti-mouse CD123 
plasmacytoid DCs 
PE CY7 6H6 306009 Biolegend  
Anti- human CD33 
myeloids 
APC WM53 303407 Biolegend 
Anti- human CD14 
monocytes 
APC H7 M5E2 561384 BD 




Bu15 337225 Biolegend 
Mouse FC block clone 
2.4 G2 
None  93 101320 Biolegend 
Human FC block None None 422302 Biolegend 
Cell staining buffer None None  420201 Biolegend 
Table5. Organ innate FACS panel 
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Ab FLUOROPHORE clone Catalog 
number 
Company 




H130 304036 Biolegend 
Anti-mouse CD45  
leukocytes 
Alexa Fluor700 30-F11 103128 Biolegend 
Anti- human CD19 B 
cells 
PE  HIB19 302208 Biolegend 
Anti-human CD45 RA 
naïve T cell marker 
PECF 594 HI 100 562298 BD 
Anti-human CD197 
(CCR7) memory T cell 
marker 
PERCP CY5.5 150503 561144 Biolegend 
Anti- human CD4 
Helper T cells 
PE CY7 SK3 355612 Biolegend  
Anti- human CD20 B 
cells 
APC 2H7 302310 Biolegend 
Anti- human CD8 
Cytotoxic T cells 
APC H7 SK1 560273 BD 
Anti- human CD3 T cells Brilliant violet 
421 
Ucht1 300434 Biolegend 
Mouse FC block clone 
2.4 G2 
None  93 101320 Biolegend 
Human FC block None None 422302 Biolegend 
Cell staining buffer None None  420201 Biolegend 
Table6. Organ adaptive FACS panel 
Cell isolation for biomolecules characterization 
After aseptic removal, the lungs and spleen were transferred into sterile M tube (Cat #: 130-
093-236; Miltenyi Biotec) containing 1 ml of homogenate mix. The homogenate mix recipe used 
was 50 ml PBS/Tween 20 0.5% (Cat #: 9005-64-5; Sigma Aldrich) in which one protease inhibitor 
tablet (Cat #: 04693159001; Roche) was dissolved. A mechanical tissue dissociator 
(gentleMACS™ Miltenyi) on a protein program was used to make single cell homogenates. The 
M tubes underwent centrifugation at 1500rpm for 5 minutes at 4oC in order to retrieve more 
sample material. The homogenate was transferred into 1.5 ml screw cap tube (Cat #: 
72.692.005; Sarstedt) and underwent centrifugation at 20,000 rpm for 2 minutes. The 
supernatant was transferred into two separate spin-x tubes (Cat #: CLS8160; Corning Costar) 
and underwent centrifugation at 8000 rpm for 5 minutes at 4oC to remove Mtb bacteria. The 
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flow through was transferred into fresh sterile 1.5 ml screw cap tubes, the outside wiped down 
with 4% Melsept and stored at -80oC in the biosafety level 2 until further analysis. 
Biomolecules characterization 
The cytokine and chemokine concentrations in the plasma and cell homogenates were 
measured using the Bio-Rad Bio-Plex Pro Human Cytokine 27-plex Panel (Cat #: M50-0KCAF0Y) 
and the Bio-Rad Bio-Plex Pro Mouse Cytokine 23-plex Panel (Cat #: M60-009RDPD). The isotype 
concentrations in the plasma and cell homogenates were measured using Bio-Rad Bio-Plex Pro 
Human isotyping (Cat #: 171A3100M). In all multiplex assays, the volume of the coupled beads, 
detection antibodies and streptavidin-PE conjugate was halved and capped up with the 
appropriate buffer to the required volume. Then the assays were performed according to the 
manufacturer’s instructions. Assay plates were read using the Bio-Rad Bio-Plex 200 system. 
Preparation of Organ histology blocks 
Paraffin blocks 
Organs were fixed in 50 ml tubes containing 30 ml 4% w/v PFA for 24 hours at 4°C. These organs 
were placed in embedding cassettes and were dehydrated sequentially in 30%, 50%, 70%, 80%, 
90%, 95% and 100% ethanol (EtOH) (Cat #: 459836; Sigma Aldrich) for 2 hours each. The organs 
were subsequently incubated in xylol (Cat #: 296325; Sigma Aldrich) for 1 hour. The organs were 
then placed in melted paraffin (Cat #: 03897; Sigma Aldrich) at 56-58oC for 2 hours and were 
then transferred into a new paraffin bath for an additional 2 hours. The next day, the organs 
were placed in an embedding mold and submerged in melted paraffin to form histology blocks. 
The paraffin tissue blocks were cooled on -20oC ceramic slab for 4 hours. The blocks were stored 
at room temperature until sectioning. Histology blocks were first trimmed then were cut to   
two- to three-μm thick sections on a microtome (Leica). Sections were floated in a 42oC water 
bath and were fished out using super frost microscopy slides (Cat #: 10143351; Thermo Fisher). 
The slides were then dried for 24 hours in a 37oC incubator. Paraffin sections were 
deparaffinized sequentially in xylol, xylol, 100% EtOH, 95% EtOH, 80% EtOH, 70% EtOH, 50% 
EtOH and water for 10 minutes each in order to begin the various histological stains. 
Pathological analysis 
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Hematoxylin and eosin stain 
The deparaffinized sections were transferred from water and immersed in Harris hematoxylin 
solution (Cat #: HHS128; Sigma Aldrich) for 5 minutes at RT. The slides were rinsed in cool 
running water for 5 minutes. The slides were then repeatedly immersed in 0.3% acid alcohol for 
30 seconds and then rinsed in cool running water for 1 minute. The slides were then immersed 
in Eosin Y solution (Cat #: 230251; Sigma Aldrich) for 2 minutes at RT. The slides were repeatedly 
immersed in cool running water for 1 minute. The slides were then dehydrated sequentially in 
30%, 50%, 70%, 80%, 90%, 95%, 100% ethanol and xylol for 5 minutes per solution. Coverslips 
(Cat #: 1014355123NR15; Thermo Fisher) were affixed to the slides with mounting medium (Cat 
#: SP15; Thermo Fisher) to protect the tissue sections.  
Ziehl-Neelsen stain 
The deparaffinized sections were transferred from water and immersed in a working solution of 
fuschin from the Roth Ziehl-Neelsen staining kit (Cat #: 8276.1) that had been pre-heated at 58-
60 oC in a coplin jar placed in a water bath. The slides were kept in the heated solution for 15 
minutes. The slides were removed from the coplin jar and were rinsed in cool running water for 
1 minute. The slides were then repeatedly immersed in 3% hydrochloric acid in 95% ethyl 
alcohol for 1 minute. The slides were rinsed in cool running water for 3 minutes and then 
immersed in hematoxylin gill number 2 (Cat #: GHS216; Sigma Aldrich) for 30 seconds. The slides 
were repeatedly immersed in cool running water for 1 minute. The slides were then dehydrated 
sequentially in 30%, 50%, 70%, 80%, 90%, 95%, 100% ethanol and xylol for 5 minutes per 
solution. Coverslips were affixed to the slides with mounting medium to protect the tissue 
sections.  
Immunohistochemistry 
The deparaffinized sections were then subjected to a heat-induced epitope retrieval step by 
steaming under high pressure for 3 minutes in Target retrieval solution, pH 9(Cat #: S236784-2; 
Dako Agilent Technologies). The sections were cooled in the buffer for 30 minutes and further 
rinsed in cool running water for 10 minutes. Endogenous peroxidase was blocked by incubating 
the sections in 3% H2O2 (Cat #: 95299; Sigma Aldrich) for 10 minutes at RT. The sections were 
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rinsed under cool running water for 5 minutes and then further washed in Tris-buffered saline 
Tween 20 (TBST) for 5 minutes. The sections were blocked in rodent block M (Cat #: RBM961; 
Biocare) for 1 hour at RT in a moistened chamber. The blocking agent was decanted, and the 
sections were incubated with the following individual primary antibodies for 1 hour at RT. 
Antibody specificity was confirmed by using isotype controls. 
Ab clone Catalog 
number 
Company 
Anti- human CD20 B 
cells 
L26 M0755 Dako Agilent 
Anti- human CD3 T cells F.2.38 M7254 Dako Agilent 
Anti- human CD15 
neutrophils 
KP1 M0814 Dako Agilent 
Anti-human CD68 
macrophages 
None 559045 BD biosciences 
Anti- human CD4 
Helper T cells 
4B12 NCL-L-CD4-368 Leica 
biosystems 
Anti- human CD8 





Table7. Organ immunohistochemistry antibodies 
At the end of the primary antibody incubation period, the sections were washed in TBST thrice 
for 5 minutes each. The sections were then incubated for 10 minutes at room temperature with 
MACH 4 universal AP probe from the MACH 4 Universal AP Polymer kit (Cat #: M4U536; Biocare) 
with another incubation of 10 minutes at RT with the MACH 4 MR AP Polymer from the kit. The 
sections were washed in TBST thrice for 5 minutes each and then incubated in 100ul of DAB 
substrate (Cat #: K3468; Dako Agilent) for less than 1 minute at RT. The sections were quickly 
immersed in cool running water and counterstained with hematoxylin for 40 seconds. The slides 
were washed in cool running water for 10 minutes and then slides were then dehydrated 
sequentially in 30%, 50%, 70%, 80%, 90%, 95%, 100% ethanol and xylol for 5 minutes per 
solution. Coverslips were affixed to the slides with mounting medium to protect the tissue 
sections.  
Tissue sections were imaged using a Leica DRMB microscope with a ProgResC12 (Jenoptik) 
Camera. Lung tissue sections were scanned using Aperio AT2 Leica slide scanner. 
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Table8. Cohort for model establishment 
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Results 
Establish the model 
Human immune reconstitution of NOD/SCID/IL2r null mice 
Newborn (1-3 days old) NOD/SCID/IL2r null (NSG) mice received human fetal liver CD34+ HSCs 
via intra-hepatic injection after undergoing sub lethal irradiation of 100 cGy. The mice were bled 
10 weeks post engraftment and peripheral leukocytes were analyzed via flow cytometry to 
assess the reconstitution of the human immune cells in comparison to human donor blood.   
 
Figure15. Generation of Human Immune System mice. Newborn NSG pups were sublethaly irradiated 
and subsequently injected with HSCs or PBS. At 10 weeks post-injection, human immune reconstitution 
levels was checked in the peripheral blood via flow cytometry analysis for common leukocyte marker 
CD45. 
Frequencies of human CD45 pan-leukocytes exceeded 2% in the blood by 3 months and were 
quite variable between each mouse (2-80%) and each donor graft (> 9 donors). Peripheral blood 
human CD45+ cells developed into granulocytes, monocytes and lymphocytes (Figure 16). The 
lymphocytes consisted CD4+ helper T cells, CD8+ cytotoxic T cells and CD19+ B cells (Figure 17). In 
my hands, in line with previous findings, reconstitution of the human immune system was 
successfully achieved and these mice were termed HIS NSG (204). Depending on the size and 
age of the fetal liver (16-24 weeks), cohorts of 10-50 mice were generated per individual donor 
graft. Simultaneously, some of the NSG littermates underwent the same conditioning but were 
injected with phosphate buffer saline (PBS). These mice were termed PBS NSG and were used as 
controls. 
 




HSC or PBS intrahepatic 
innoculation HIS or PBS NSG mice- 10 
weeks old 
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Figure16.  Human immune cells reconstitution in peripheral blood. Representative dot plots of human CD45 and 
mouse CD45 cells. Dot blots show flow cytometric gating strategy applied to identify human leukocytes populations 
(FSC/SSC leukocytes→ human CD45+ leukocytes → human CD3+ T cells/human CD19+ B cells → human CD4+ helper 
T cells and human CD8+ cytotoxic T cells)  
 
Figure17. Human immune cell frequencies in peripheral blood. Frequencies of the respective immune 
compartments in the peripheral blood of HIS NSG mice 10 weeks post-transplantation (n=23) reconstituted from 
the same donor are shown. Each symbol represents an individual mouse. Frequencies of CD3+ T cells and CD19+ B 
cells within human CD45+; and frequencies of CD4+ and CD8+ T cells within CD3+ cells are indicated. Horizontal bars 
represent means. 
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Figure18. Human immune cells reconstitution in naïve lung. Representative tissue sections of HIS NSG mice lung 
10 weeks post-transplantation. (A) Hematoxylin and Eosin 400X, scale bar=40um. Immunostaining with human 
CD68 (B), human CD15 (C), human CD3 (D) and human CD20 (E) at magnification of 400X, scale bar=50um 
 
A. 
CD68 macrophages B. 
HIS NSG Naïve Lung 
CD15 neutrophils 
     CD3 T cells CD20 B cells 
C. 
D. E. 
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To determine the extent of human immune cell reconstitution and penetrance in the main 
organ of interest-the lung; some HIS NSG mice were sacrificed and immunohistochemistry using 
human antibodies was carried out on lung tissue sections as described in the material and 
methods. Naïve HIS NSG lung tissue morphology had a sponge like appearance with large 
alveolar spaces (Figure 18A) with a spatial distribution of alveolar CD68 macrophages (Figure 
18B box) and parenchymal CD68 macrophages (Figure 18B oval). CD15 neutrophils (Figure 18C 
box), CD3 T cells (Figure 18D) and CD20 B cells (Figure 18E box) were also detected and these 
cells were located in the lung parenchyma. Collectively, these findings show that the HIS NSG 
mice generated in this cohort had the essential human immune cells that are necessary for 
Mycobacterium tuberculosis infection studies. 
Gross characterization of Mycobacterium tuberculosis infection in HIS NSG mice 
A cohort of 12 weeks post-engraftment HIS NSG and PBS NSG mice were infected with an ultra-
low dose of aerosolized Mtb H37Rv (15-30 CFU). HIS NSG mice in this cohort had frequencies of 
human CD45+ in the peripheral blood ranging from 10-50% pre-infection. In addition, 12 week 
old C57BL/6 (B6) mice; the mouse strain traditionally used in TB research were simultaneously 
infected at this dose as a supplementary control (Figure19).  
                   
                            
     
 
Figure19. Aerosol tuberculosis infection of HIS NSG mice. Experimental scheme of 12 weeks post engrafted HIS 
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Macroscopic and microscopic examination 
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All the HIS NSG and PBS NSG mice exhibited clinical symptoms such as lethargy and weight loss 
starting from day 25 post infection (Figure 20A). In contrast, the B6 mice maintained and even 
gained weight from day 25 post infection in accordance with previously published reports (257). 
The HIS NSG and PBS NSG mice succumbed to infection by day 33 to day 35 post infection 
(Figure 20B), indicating that the HIS NSG and PBS NSG mice are susceptible to an ultra-low dose 
of aerosolized TB. 
 
Figure20. HIS NSG mice are susceptible to aerosolized tuberculosis. HIS NSG mice (n=10), PBS NSG mice (n=10) 
and B6 mice (n=10) after ultra-low dose aerosol infection with H37RV were monitored for (A) weight loss and (B) 
survival- Kaplan-Meier. This figure is representative of three independent experiments. (*** p<0.001, ** p<0.01) 
  
Postmortem macroscopic examination was performed on major organs at day 35 post infection. 
All three groups were observed to have lung lesions (Figure 21C). In addition, we observed that 
HIS NSG and PBS NSG mice exhibited splenic lesions/granulomas (Figure 24B) and spotting on 
the liver and kidneys. No gross pathological changes were observed in other organs. Bacterial 
loads were enumerated in the lung, spleen, liver, kidney and bone marrow of HIS NSG and PBS 
NSG mice. The immunodeficient background of the NSG mouse precludes lymphnode 
development due to a lack of murine T cells and B cells; hence a comparison of HIS NSG 
lymphnodes to PBS NSG lymphnodes was not feasible (Figure 25D). The lung bacterial load and 
lung weight/body weight ratio of HIS NSG was significantly lower than that of PBS NSG by day 35 
post infection (Figure 21A and B). The bacterial load in other organs such as the spleen (Figure 
22A), liver (Figure 25A), kidney (Figure 25B) and bone marrow (Figure 25C) was similar in the HIS 
NSG and PBS NSG mice. This data indicates that there was active bacterial replication in the lung 
followed by bacteria disseminating to other organs of interest as the disease progressed.  
A. B. 






                                                                          
 
          
          
         
Figure21. HIS NSG mice develop lung lesions upon Mtb infection. Bacterial burden (A) and lung/weight ratio (B) 
was determined at day 35 post infection. Macroscopic (C-Photographs) and microscopic analysis (D-Hematoxylin 
and Eosin 25X, scale bar=1000um) of lesions in representative HIS NSG, PBS NSG and Black 6 lungs was performed 
in addition to Mycobacterial identification (E-Ziehl-Neelssen 50X, scale bar=500um). Data was pooled from three 
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In order to determine if a human like disease pathology was developed following Mtb infection, 
hematoxylin and eosin analysis was performed on left lung tissue sections. In B6 lungs at day 35 
post infection, the lesionss were comprised of non-necrotic aggregates made up of 
macrophages surrounded by lymphocytes (Figure 21D). Day 35 post infection PBS NSG 
granulomas on the other hand consisted of non-necrotic myeloid aggregates (Figure 21D). 
Meanwhile, HIS NSG lungs at day 35 post infection contained various granulomas which ranged 
from small non-necrotic myeloid aggregates, coalesced lung parenchyma and most interestingly 
caseous necrotic granulomas (Figure 21D and 22A). The caseous necrotic granulomas had a core 
that consisted of myeloid necrotic debris; an inner myeloid rim and an outer lymphocyte cuff 
(Figure 21D). This pathology is a characteristic feature seen in most active TB patients (Figure 
22B). A characteristic of human TB granulomas called langhans giant cells which arise when 
epitheloid macrophages are fused, (Figure 22B arrow heads) were not found in HIS NSG 
granulomas.  
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Figure22. HIS NSG mice develop human like caseous necrotic granulomas. Various lesions were observed in 
representative HIS NSG lung sections (A); S=solid non-necrotic granulomas, CP=coalesced parenchyma and 
CN=caseous necrotic granuloma. HIS NSG caseous necrotic granuloma was compared to one from a TB patient. 
Arrows indicate in human sample indicate giant cells. Tissue slide scan, Hematoxylin and Eosin 50X, scale 
bar=500um 
To determine bacteria location, ziehl niellsen staining was performed on lung tissue sections. B6 
and PBS NSG myeloid aggregates contained intracellular bacilli (Figure 21E) whereas the HIS 
NSG caseous necrotic granulomas had extracellular bacteria in the necrotic core (Figure 23) and 
intracellular bacteria in the myeloid inner rim (Figure 23). This data supports the speculation 
that Mtb is an intracellular pathogen that changes the host environment to become more 
extracellular in readiness for transmission.    
                                    
 
          
    
Figure23. HIS NSG mice caseous necrotic granulomas have Mtb in the center. A higher power view (B) of a Ziehl-
Neelssen stain was taken of a representative HIS NSG lung (A) in order to demonstrate the zones in which 
intracellular and extracellular Mtb are located in caseous necrotic granulomas. (50X, scale bar=500um; 400X, scale 
bar=50um) 
Splenic caseous necrotic granulomas whose centers were filled with extracellular bacteria were 
also observed in HIS NSG mice day 35 post infection (Figure 24B, C and D), whereas PBS NSG 
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bacteria. There were no granulomas in the B6 spleen at day 35 post infection with few to 
undetectable intracellular bacteria. Collectively, these data suggests that the HIS NSG mouse 






                   
        
              
       
Figure24. HIS NSG mice develop splenic lesions upon Mtb infection. Bacterial burden (A) was determined at day 
35 post infection. Macroscopic (B-Photographs) and microscopic analysis (C-Hematoxylin and Eosin 50X, scale 
bar=500um) in representative HIS NSG, PBS NSG and Black 6 spleens was carried out in addition to Mycobacterial 
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Figure25. HIS NSG mice show signs of disseminated TB in other organs. Bacterial burden was determined at day 
35 post Mtb infection in HIS NSG and PBS NSG liver (A), kidney (B), bone marrow  (C) and in cervical, axial and 
brachial lymphnodes (D). Data was pooled from two independent experiments. (n.s. =no significance) 
 
Kinetics of the pulmonary human immune response post Mtb infection 
 
In order to broadly characterize the lung transformation from a myeloid spongy architecture to 
a myeloid/lymphoid organized biomass; minimal cell phenotype, biomolecules, bacterial burden 
and cellular spatio-organization was assesed in HIS NSG mice in additional cohorts at specific 
time points. These time points were days 14, 21 and 28 post infections (Figure 26). The HIS NSG 
mice in these cohorts had frequencies of human CD45+ in the peripheral blood ranging from 5-
54% pre-infection and were aerosoly infected with 20-50 CFU Mtb.  
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Figure26. Aerosol tuberculosis infection of HIS NSG mice. Experimental scheme of 12 weeks post engrafted HIS 
NSG mice with experimental readouts that were carried out on a time course of days 14, 21 and 28 post infection. 
 
It was observed that; at day 14 post-infection, bacteria was still contained in the lung (Figure 
27A), but had disseminated to other organs such as the spleen, liver, kidney and bone marrow 
by day 21 post infection lung (Figure 27 B, C, D and E). There was a 2 log increase from day 14 to 
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Figure27. Tuberculosis disseminates from HIS NSG lungs as the disease progresses. Bacterial burden was 
determined at days 14, 21 and 28 post Mtb infection in HIS NSG lung (A), spleen (B), liver (C) kidney (D and bone 
marrow (E). Data was pooled from three independent experiments for lung, spleen and kidney; n= 6 mice per time 
point (*** p<0.001, * p<0.05). 
 
Human leukocytes consisting of cells that are members of the innate and adaptive branches 
(Figure 28) were observed to infiltrate the lungs in increasing numbers from day 14 to day 28 
post infection via flow cytometric analysis. There was a notable increase of human neutrophils 
defined as CD45+CD33+CD66+, human dendritic cells defined as CD45+CD33+CD11c+ and human  
monocytes/macrophages defined as CD45+CD33+CD14+ in the lungs by day 28 post infection 
(Figure 29). The human CD45+CD3+CD4+ T cells, human CD45+CD3+CD8+ T cells and human 
CD45+CD19+CD20+ B cells also increased in the lungs by day 28 post infection, albeit at lower 

























                                                                
                                        
 
 
Figure28.  Human immune cells in HIS NSG lung. Representative dot blots show flow cytometric gating strategy 
applied to identify human innate and adaptive cells(FSC/SSC leukocytes→ human CD45+ granulocytes → human 
CD33+CD66+a/c/e/b neutrophils; FSC/SSC leukocytes→ human CD45+ monocytes→ human CD33+CD14+ 
monocytes/macrophages; FSC/SSC leukocytes→ human CD45+ monocytes→ human CD33+ CD11c+ dendritic cells; 
FSC/SSC leukocytes→ human CD45+ lymphocytes → human CD3+ T cells and CD19+ B cells; human CD3+ T cells→ 
CD4+ T cells and CD8+ T cells 
 





Cytotoxic and helper T cells Mature B cells 







                                         











Figure29.  Human immune cells are recruited to the HIS NSG lung upon infection. Line graphs showing the 
absolute numbers of cells infiltrating the lung at time points 14, 21 and 28 post Mtb infection. Data from one 
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Kinetics of the human immune response in non-lung organs post Mtb infection 
 
In order to assess whether Mtb infection also induces an immune response in other organs such 
as the spleen and bone marrow, flow cytometry analysis was also performed in these organs. 
Human immune cells of the innate and adaptive branches were also recruited into the spleen 
from day 14 to day 28 post infection. In contrast to the lung, whence the innate cells were 
recruited in vast numbers, the greatest number of recruited cells in the spleen consisted of 
human CD45+CD3+CD4+ T cells and human CD45+CD3+CD19+CD20+ B cells (Figure 30B). Human 
CD45+CD33+CD66+ neutrophils were still the largest population of spleenic innate cells by day 28 
post infection, followed by human CD45+CD33+CD11c+ dendritic cells and human  CD45+ 
CD33+CD14+ macrophages (Figure 30A). Interestingly in the bone marrow, the human 
CD45+CD33+CD11c+ dendritic cells (Figure 30C) were recruited to the bone marrow while the 
human CD45+CD19+ B cells eggresed out of the bone marrow (Figure 30D). Thus these human 
CD45+CD33+CD11c+ dendritic cells may be migratory DCs carrying antigens and whole bacteria 
into the bone marrow while the human CD45+CD19+ B cells seem to be immature B cells that 
are egressing out of the bone marrow to required sites such as the lung and the spleen were 
they matutre to CD45+CD19+CD20+ B cells. This collective data from the lung, spleen and bone 
marrow shows a dynamic movement of various immune cells between different organs in order 
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Figure30.  HIS NSG mice have a systemic immune response upon infection. Line graphs showing the absolute 
numbers of cells infiltrating the spleen and infiltrating/egressing in the bone marrow at time points 14, 21 and 28 
post Mtb infection. Data from one representative experiment out of three independent experiments, n= 6 mice per 
time point (*** p<0.001, ** p<0.01) 
 
Kinetics of the human pulmonary biomolecules post Mtb infection 
 
Immune/inflammatory biomolecules are involved in the recruitment of the various cells that are 
crucial in granuloma initiation and development; hence these biomolecules were assesed in 
lung homogenates. These biomolecules were categorized as pro-inflamatory cytokines, Th17 
cytokines, Th2 cytokines, T cell regulation cytokines, T cell activation cytokines, chemokines, 
growth factors and B cell antibodies (Table 10). There was an increase in pro-inflammatory 
cytokines such as TNF-a, IL-1b, IL-6 and IFN-g and an increase in chemokines such as MCP-1 and 
IP-10 from day 14 to day 28 postinfection (Figure 31). There was also an increase in the anti-
inflammatory IL-10 cytokine and a significant increase in the human specific neutrophil 
associated pro-inflamatory IL-8 chemokine. Furthermore, mucosal IgA antibody also significantly 
increased as the disease progressed. This mostly pro-inflammatory response is consistent with 
previous studies carried out in other animal models and TB human lung samples (ref). Thus the 
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Figure31.Human biomolecules are secreted in the HIS NSG lung upon infection. Bar graphs showing 
representative cytokines, chemokines and antibodies produced in the lung at time points 14, 21 and 28 post mtb 
infection. Data from one representative experiment out of two independent experiments, n= 6 mice per time point 
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Category Comment 
Proinflammatory Significant increase: IL-8, IL-1β, IL-6, IL-1ra 
Increase: IFN-g, TNF-α 
Not detected: IL-2, IL-15 
Th17 Not detected: IL-17 
Th2 Increase: IL-9 
T cell regulation Increase: IL-10 
T cell activation No difference: IL-12p70 
Chemokine Increase: MCP-1, Eotaxin, Basic FGF, MIP1-α, 
MIP1-β, IP-10, RANTES 
Growth Factor Increase: G-CSF, GM-CSF, PDGF-BB, VEGF 
Antibody Significant increase: IgA, IgM 
Increase: IgG1; IgG2, IgG3, IgG4 
No difference: IgE 
Table10. Biomolecules characterized in HIS NSG lung 
Spatial-organization of the lung human immune cells post Mtb infection 
Biomolecules not only influence cell migration, but also influence cellular spatio-organization. In 
order to asses the reorganised lung architecture, left lung sections were stained and 
independently graded by a clinical pathologist (Provitro/ Charite Perlin Pathology). At day 14 
post infection most HIS NSG lungs consisted of small non-necrotic myeloid aggegrates 
surrounded by lymphoctes and non-involved tissue (Figure 32). At day 21 post infection, the 
lungs were mostly made up of coalesced parenchyma known as tuberculosis pneumonia while 
at day 28 post infection, granulomas consisted of a number of large non-necrotizing granulomas 
and large caseous necrotic granulomas with smaller adjacent caseous necrotic granulomas 
(Figure 32). Some HIS NSG mice regardless of the initial stem cell donor, had small caseous 
necrotic granulomas at day 14 and day 21 post infection; giving credence to the speculation that 
granuloma development is not necessarily linear in progression (ref). Cumulatively, these data 
demonstrates that the HIS NSG mouse has the ability to model lung granuloma initiation and 
formation with the associated human pulmonary immune response. 
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Figure32. HIS NSG lung architecture changes as the disease progresses. Entire left lung lobes collected from 
representative HIS NSG mice at time points 14, 21 and 28 post Mtb infection showed increased loss of spongy 
architecture as the disease progressed. Hematoxylin and Eosin stain Tissue slide scan; Hematoxylin and Eosin stain 
100X, scale bar=200um 
Sequential lung tissue sections were also stained with CD68 macrophages, CD15 neutrophils, 
CD4 T cells and CD20 B cells in order to visually confirm the cell infiltration observed via flow 
cytometry. As the disease progressed, the lung infiltrates got more organized with the 
macrophages and neutrophils in the center, with more macrophages and neutrophils making an 
inner rim followed by T cells and B cells making an outer cuff by day 28 (Figure 33). In particular, 
caseous necrotic granulomas in the HIS NSG day 28 post Mtb infected lung had cell phenotypes 
that were organized in a pattern similar to that observed in active pulmonary TB patients (Figure 
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Figure33. Recruited human immune cells develop a human like organization. Microscopic analysis (Hematoxylin 
and Eosin 20X, scale bar=1000um) in representative HIS NSG lungs at d14, 21 and 28 post infection was carried out. 
In addition, Human immune-stains of CD68 macrophages, CD15 neutrophils, CD4 T cells and CD20 B cells was also 
performed (100X, scale bar=200um).           
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Figure34. Enhanced view of human like organization in HIS NSG lung. An enlarged high power view of human 
immune-stains of CD68 macrophages, CD15 neutrophils, CD4 T cells and CD20 B cells taken of a representative HIS 
NSG lung in order to compare to a human TB sample( 400X, scale bar=50um) 
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Discussion 
Human Immune System mouse as a model for Pulmonary Tuberculosis infection 
As Robert Koch told his students; “Gentlemen, remember mice are not men” hence, even 
though the observations stated in this thesis add another animal model to the established 
coterie, caution should be taken in interpreting these results as the HIS mouse is still a chimera. 
Nevertheless, the purpose of a model is to restrict a system in a manageable format to provide 
answers despite certain limitations (279). These limitations include the presence of murine 
innate system, murine endothelium, murine epithelium and murine stroma. Hence, though the 
generated human mononuclear phagocytic network readily engulfs Mtb, some of the residual 
murine innate system and murine non-hematopoietic system also phagocytize Mtb. This dual 
species phagocytosis could influence the immune response that is consequently generated and 
this could have an influence on the end point pathology that has being described in this thesis. 
The first question I posed in this model was the feasibility of using the fetal liver stem cell HIS 
mouse to investigate the development of pulmonary granulomas subsequent to aerosol Mtb 
infection. In this thesis I have therefore introduced a new small animal model that does develop 
human-like caseous necrotic granulomas containing human immune cells as the disease 
progresses. Furthermore, heterogeneous granuloma pathology in individual HIS mouse lungs 
samples and across various stem cell donors was also observed. These human-like granulomas 
had an immunephenotype and spatial organization reminiscent of pathological samples 
observed in some human patients; in particular to what is observed in pediatric or 
immunocompromised patients (232, 281). These granulomas ranged from solid non necrotic 
granulomas, tuberculoid pneumonia and caseous necrotic granulomas. This granuloma 
heterogeneity exhibited by the various donors is in line to what has been observed in infected 
NHPs but is lacking in traditional inbred mouse strains.  
Nevertheless, there was one particular granuloma type absent in the HIS NSG mouse. These are 
cavitary granulomas which are observed in the upper lobes of 40-87% pulmonary TB patients. 
Cavitary granulomas are of great interest in terms of disease transmission, treatment response 
and the development of antibiotic resistance (282). Cavitary granulomas have been reported to 
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develop in some NHPs (39) and in rare instances in rabbits (283) and in the Kramnik mouse 
(284). A hodgepodge of reasons could explain the development of cavitary tuberculosis 
granulomas in humans and non-human primates but not in the HIS mouse. These include 
anatomical differences between large and small mammals, one primary infection versus 
multiple reinfections, sensitization prior to infection and the age at which TB infection occurs 
(child or adult) (285). 
NHPs and humans are upright mammals whose lungs are anatomically designed as 3 right lobes 
and 2 left lobes while mice have 4 right lobes and 1 left lobe. NHPs and human lungs also have 
interlobular septae which helps in supporting lung weight (286). This interlobular structure is 
lacking in mice and rabbits. Due to the effects of gravity and being upright; the upper lobes have 
a higher alveolar pressure, higher diameter, reduced capillary density and less mobility (285, 
287). The upper lobes also have less lymphatic drainage, less connectivity to the regional 
lymphnodes and less immunosurvelience in comparison to the lower lobes (285, 288). 
Therefore at the height of the infection all these factors in addition to lower breathing 
amplitude (289, 290) could allow for an increase in the number of bacilli in the upper lobe. This 
leads to an increased number of infected macrophages, an increased number of recruited 
neutrophils and eventually a necrotic cascade that is speculatively believed to lead to 
granuloma liquefecation and finally caseation. The correlation between being upright and the 
increased probability of developing cavitary granulomas in the upper lobes was shown in Mtb 
infected rabbits that were kept upright in a harness for 11 hours each day (291). Cavitation in 
rabbits was also observed upon using a clinical Mtb strain suggesting that the virulence of the 
bacteria could play a role in the development of cavitary TB (283). Further supporting this link 
are studies done in the Kramnik mouse using clinical strains of Mtb (284). Therefore, in order to 
test the feasibility of the HIS mouse as a possible model of cavitary TB; experiments that take 
into account upper lobe pressure differences by the use of harnesses and bacteria virulence by 
the use of clinical strains would be desirable. Further experimental conditions such as 
reinfection or mixed strain infections (292) instead of the single infection carried out in this 
thesis could also be employed, as there is speculation that a person who is exposed to greater 
than 6 hours per day to an active TB patient over a consistent period of time has a greater 
likelihood of developing cavitary TB (293, 294). 
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All HIS NSG and PBS NSG infected mice exhibited some clinical features of TB such as weight loss 
showing susceptibility to infection. The cough clinical feature was not observed since mice do 
not have the family of airway epithelial nerves that can trigger the cough reflex (296). Hence the 
HIS NSG mouse in this thesis was not used as a model for transmission. In some murine models 
for human pneumonia (298), cough was induced by making the mice inhale capsaicin (299). This 
form of mechanical stimulation could be applied in future HIS NSG studies in order to study Mtb 
transmission dynamics (303). 
All HIS NSG and PBS NSG infected mice showed signs of disseminated TB in organs such as the 
spleen, liver, kidney and bone marrow which is another feature of susceptibility to infection. 
The HIS system that develops in these humanized mice has more in common with a human 
newborn infant or an immunocompromised individual than with an immunocompentent adult 
individual (296, 297). This is due to the fact that the stem cells were acquired from fetal material 
that developed in a sterile environment (the womb) with minimal contact with pathogens and 
foreign antigens. In addition, the mice were kept in specific pathogen free facility; hence, these 
mice had a naïve phenotype-low functionality immune system in comparison to a free living 
human adult. In regards to bacterial infection, human newborns and children due to this naïve 
phenotype-low functionality immune system are more susceptible to infection and exhibit 
disseminated pathology in comparison to human adults whom display cavitary TB (300, 301). 
Undeniably, human newborns are one of the greatest groups at risk for mortality and morbidity 
to infection (WHO Global health observatory data 2015). Indeed, the primary purpose of the 
BCG vaccine is to prevent disseminated TB and TB meningitis.  
By histological analysis, no TB was seen in the meninges, brain or spinal cord. This could be due 
to the ultra-low dose single infection administered to the HIS mice in comparison to multiple 
reinfections with clinical strains in a high exposure household. Clinical strains of Mtb have been 
shown to cross in vitro human blood brain cultures (302) and specific Mtb genotypes have been 
found in patients’ cerebrospinal fluid (304). This suggests that virulence plays a role in the 
degree of cerebral TB exhibited. This was confirmed in vivo by infecting BALB/C mice via the 
intratracheal route with specific Mtb genotypes isolated from patients’ cerebrospinal fluid 
(305). The cerebrospinal isolates caused infection and inflammation in the brain and the 
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meninges while the H37RV strain hardly infected the brain. This places more emphasis in 
carrying out studies in the HIS mice using clinical strains of Mtb. Furthermore, incorporating 
fluorescent bacteria, fluorescent tracers and whole mount immunohistochemistry will aid in 
deciphering a brain-cerebrospinal-cervical lymphnode-lymphatic connection separate from the 
traditional blood brain barrier (306), and add knowledge on the dissemination route from the 
lung to the brain. 
Another example of how susceptible the HIS NSG mice used in this thesis where is by the time 
frame in which they succumbed to disease. B6 mouse or BalbC mice are usually infected with 
200CFU and at this dose, their immune system controls the disease for greater than 100 days. 
Meanwhile, HIS NSG mice used in this thesis succumbed by 5 weeks post infection while 
Calderon et al engrafted BLT mice succumbed to disease 8-10 weeks post Mtb infection (242). 
None of the HIS mice in this thesis and in the Calderon BLT study developed any form of latency, 
thus showing that the HIS NSG mouse model is optimally used for active progressive disease due 
to its original immune deficient background and stem cell source. Therefore, future experiments 
using the Cornell model as a template could be performed in other to get a more latent-like 
disease. The Cornell mouse model is a form of latency model whence upon Mtb infection; the 
mice are given the antibiotics isoniazid and pyrazinimide approximately 20 minutes after 
infection (307). This forms an environment of no detectable bacilli in the organs and upon 
immunosupresion the development of reactivated TB (308). As antibiotics are used, this does 
not reflect the true latency/subclinical form that are observed in NHPs and humans. 
Nevertheless, an adaptation of the Cornell system to the HIS mouse could provide information 
on drug related latent TB. Recent genetic manipulation of the NSG mouse embryos by 
CRISPR/Cas 9 technology (309) could lead to a range of susceptible to resistant mice that could 
still allow for human engraftment. It is conceivable that upon infection, these range of NSG mice 
could exhibit severe active progressive TB to latent TB as has been currently done in immune-
competent diversity outbred mice (310). 
On the cellular level, the characteristic langhans multinucleated giant cells associated with TB 
granulomas was not observed in the HIS NSG lung samples. Giant cells arise after some 
macrophages fuse due to an initial reaction with a foreign biomaterial or infectious agent (311). 
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Giant cell formation seems to be linked to virulence as studies done in an in vitro model of 
human granuloma with highly virulent Mtb resulted in giant cells with greater than 15 nuclei per 
cell (312). These giant cells also had a lower phagocytic capacity. Specifically, Mtb lipomannan a 
proinflammatory glycolipid induces GAMs to fuse via a TLR2, ADAM- and beta1 integrin pathway 
(313). The Mtb strain used in this thesis was the lab strain H37RV that had undergone prior 
passaging and freeze-thaw cycle. After thawing, the stock is diluted and sonicated to prepare 
single cell suspension of the approximate infectious dose requested. This process could strip 
some essential lipids from the Mtb cell wall which induce certain innate mechanisms (314, 315). 
It is also possible that giant cells arise when a series of macrophages attempt to phagocytize 
sputum contents which consists of clumped bacteria, necrotic macrophages and necrotic 
neutrophils (132, 316). instead of single bacterium as done in this thesis. 
In this thesis, most of the Mtb bacterium was detected via acid fast stain in myeloid cells. This 
shows that the murine and human myeloid cells in the HIS NSG mouse readily phagocytize TB 
bacteria. This exhibited phagocytic capability is consistent with other HIS mouse bacteria studies 
(196, 197, 198, 240). In particular, HIS mouse bone marrow derived macrophages have been 
shown to have phagocytic capabilities comparable to human monocyte derived macrophages 
(264). Even though bacterial counts in the human and mouse compartments were not 
separately delineated in this thesis; in other HIS mouse studies using pathogens that are less 
host-restricted such as Salmonella typhimurium (264) and BCG (241, 242) human macrophages 
had greater bacterial counts in comparison to mouse macrophages. Furthermore in two 
different S. aureus studies (276, 277) HIS NSG mice were more susceptible to infection and had 
a higher bacterial burden in various organs in comparison to irradiated un-reconstituted NSG 
mice, BalbC and B6 mice. This suggests that for reasons that are still unclear, the human 
mononuclear phagocytic system is more permissive to bacteria replication (233, 234). In fact, a 
study comparing alveolar macrophages from B6 mice and macaques showed that both species 
had a high induction of immune response genes in Mtb in vitro infection, but this immune 
response was species specific as there was no overlap in the genes (318). Other studies have 
shown that TLR signaling in murine macrophages depends on IRAK4 and IRAK2 while TLR 
signaling in humans is contingent on IRAK1 (319).The bacteria itself could have certain factors 
that have a higher degree of affinity for human receptors in comparison to murine receptors of 
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the same family as has been observed whence S. aeureus factors HlgBC and CHIPS preferentially 
attach to human CD88 (320). Furthermore, microarray analysis of human and murine 
macrophages hint at different internal environments that could place different stresses on 
Mtb’s DNA and its subsequent DNA repair mechanisms. For example, recX a homologous 
recombination gene for Mtb DNA repair is upregulated in mouse macrophages (321) but down 
regulated in human (322). Therefore, future experiments in which host-pathogen preferences 
could be elucidated will be by using HIS NSG EGFP mice with fluorescent reporter Mtb strains or 
DNA barcoded Mtb strains. The NSG EGCP mouse strain retains the immunodeficiency of the 
NSG background but has an additional transgenic green fluorescent protein expressed in all 
murine cells. This will allow for simultaneous quantification of human and mouse TB containing 
phagocytes. Additionally, applying single cell sorting on these particular phagocytes could also 
reveal on the transcriptomic level key species specific differences between mouse and human 
myeloid cells.  
In this thesis, not only was the Mtb bacterium detected in various granulomas by acid-fast 
staining; Mtb was also segregated into extracellular bacteria in the necrotic core and 
intracellular bacteria in the inner myeloid/lymphoid rim in the HIS NSG mouse. Mtb is primarily 
classified as an intracellular pathogen; hence a recent study showing that phthiocerol 
dimycocerosates (PDIM) a lipid in Mtb’s cell wall, increases the rate at which Mtb escapes from 
an intracellular vacuole into the cytosol thus  leading to greater necrosis hints at this later 
extracellular phase observed in a liquefied center as means of facilitating transmission (325, 
326). Furthermore, in some of the caseous necrotic granulomas, the central region of the 
necrotic core was not stained via acid fast hinting at a different micro-environment than that 
found in other parts of the same granuloma; essentially some of the bacteria lost their acid-
fastness. It is speculated that acid-fastness is lost due to cell wall thickening as has been seen in 
XDR TB samples in Iran via atomic force microscopy (343). Hence in future experiments further 
identification strategies such as using SYBR Gold in conjunction with Auramine-rhodamine and 
correlative electron microscopy would be applied in order to detect these bacteria (280). Loss of 
acid-fastness and different bacterial cell-wall phenotypes not only occurs throughout an entire 
lung tissue sample, but also within the same granuloma (232) due to factors such as hypoxia, 
pH, nutrient availability and carbon source. The ways by which these factors have influenced 
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bacteria in the granuloma have been studied in guinea pigs, rabbits, non-human primates (40), 
the Kramnik mouse (255) and the iNOS mouse (54, 261). These studies could be replicated in 
the HIS NSG mice, taking into account the role of the human immune system on these factors by 
incorporating pimonidazole to detect hypoxia (261, 324) or by carrying out structural and 
quantitative analysis on bacteria fractioned out from the different regions in the granuloma 
(323). These types of experiments will gain importance as granuloma heterogeneity (232) seems 
to be linked to the genetic heterogeneity of the bacteria (327). Granuloma and bacteria 
heterogeneity (328) are also of great importance in regards to treating Tuberculosis disease as 
the drug kinetics will have a varied range in the same individual. To thus maximize the value of 
the experimental model, future experiments could include advanced live imaging techniques 
such as single photon emission computed tomography (SPECT) with radiolabeled ligands such as 
FDG or [(125)I]iodo-DPA-713. FDG SPECT could provide live anatomical guidance further 
delineating granuloma heterogeneity in the same animal over a certain period of time (30, 
23901092). The HIS NSG mouse model is thus positioned not only to facilitate studies 
concerning host cells but also studies of the Mtb bacterium itself. 
Kinetics of the human immune response to Tuberculosis infection in HIS mice 
Following the establishment of the HIS mouse model for pulmonary Mtb infection, I extended 
the investigation to provide a human in vivo confirmation of the basic processes involved in 
granuloma initiation and development in relation to other experimental animal models such as 
the rabbit (75), guinea pig (329, 330), zebrafish embryos (331) and NHPs (332). This 
confirmation also took into account granuloma initiation and development studies carried out in 
the traditional B6 mouse, the BalbC mouse and the Kramnik mouse (255, 333).  
The overall kinetics of the human immune response to tuberculosis in the HIS NSG lung 
described in this thesis is in line with studies carried out in the previously mentioned animal 
models (334). Upon Mtb infection, monocyte/macrophages, neutrophils and dendritic cells 
where simultaneously recruited into the lungs with adaptive human immune cells such as T and 
B cells. As these human immune cells are recruited, an immune response is elicited as exhibited 
by an increase in various biomolecules such as cytokines, chemokines and antibodies that are 
secreted in the local lung tissue. This immune response was mostly pro-inflammatory and the 
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human immune cells were increasingly organized as the disease progressed. Unfortunately, the 
immune response generated is inadequate as seen by the increasing lung bacteria numbers and 
bacteria dissemination to other organs such as the bone marrow by day 28 post infection. 
Prior to infection, the lung macrophages (alveolar and parenchymal) were observed to be the 
most abundant innate cell type (335, 336) which was consistent with was has been observed in 
other studies. However, by day 28 post infection, the human pulmonary CD45+CD33+CD66+ 
neutrophils were significantly increased and were the largest population of all the human 
pulmonary immune cells. A likely explanation for these large neutrophilic numbers is that 
neutrophils are known for their quick infiltration into irritated or infected tissue (337). In fact, 
depending on the route of infection (intravenous, intradermal or intranasal) and the 
mycobacteria used (Mtb, Mycobacterium avium or BCG); murine neutrophils have been 
observed to arrive at the injection site between 2 and 24 hours post-infection (339). In effect, 
murine granulocytes accumulate for up to 21 days in an Mtb infected lung before activated T 
cells arrive (338). One of the ways by which neutrophils can rapidly arrive to a site of infection 
while causing minimal injury to the host is by softening their nuclei in order to push aside the 
blood vessels scaffolding in order to squeeze through (340).  
Neutrophils release biomolecules such as IL-10 after the dual activation of TLR2-MyD88 and C-
type lectin receptor (CLR) spleen tyrosine kinase (Syk) dependent pathway (339) which aid in 
the recruitment of other neutrophils, human CD45+CD33+CD14+ monocyte/macrophages, 
human CD45+CD33+CD11c+ conventional dendritic cells, T cells and B cells (341). Histological 
examination of the lung tissue sections at various time points post-infection served as visual 
confirmation of this innate immune cell recruitment via staining of human CD68 macrophages 
and human CD15 neutrophils. Human CD15 neutrophils were the predominant cell type in the 
center of HIS NSG lung necrotic granulomas. Furthermore, zones of inflammation and tissue 
damage were visually observed suggesting that neutrophils are initially beneficial to the host 
but subsequently detrimental when the infection is not resolved (346). Therefore, it will be 
quite interesting to study the different waves of neutrophilic recruitment in the HIS NSG mouse 
after Mtb infection is by high-resolution fluorescent live imaging of a stabilized lung (342). 
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In this thesis, the macrophages were the primary foci that anchored/interacted with the various 
immune cells as the disease progressed as was seen by increased organization of other immune 
cells around the human CD68 macrophages via immuno-stain on HIS NSG lung tissue sections. 
One possible explanation for this organization is that necrotic macrophages that contained 
degraded neutrophils and bacteria could have secreted leukotriene B4 to attract more 
neutrophils (344), while the apoptotic macrophages secreted lactoferrin to attract more 
mononuclear phagocytes (345). These newly recruited neutrophils, macrophages and dendritic 
cells act as a secondary layer (myeloid rim) which then interacts with T cells and B cells by day 
28 post infection. In comparison to the neutrophils, the conventional dendritic cells arrived in 
lesser numbers during day 14 and 21 post Mtb infection, but had greatly increased by day 28 
post Mtb infection. This lends credence to the fact that at the onset of the infection, the initial 
parenchymal human dendritic cells which are few in number migrate to the lymphnodes in 
order to present antigen to the T cells (100) while during the later stages of the infection, the 
secondary wave of human dendritic cells that arrive in the HIS NSG lung though greater in 
numbers sub optimally prime the T cells (99), leading to suboptimal bacteria control and 
dissemination to other organs. 
In this thesis, the immune cells were processed from the HIS NSG lung in bulk. However, there 
are two compartments in the lung; one is the broncho-alveolar space and the other is the 
parenchyma. Therefore, future studies that distinguish between the alveolar 
macrophages/dendritic cells in the broncho-alveolar space, the parenchyma 
macrophages/dendritic cells and newly differentiated macrophages/dendritic cells from 
recruited monocytes (347) could be carried in the HIS NSG mice as all these different innate cells 
could have different phenotypes in terms of activation (348) or metabolic status (349) which will 
affect the quality of the active immune response at different time points. Moreover, additional 
studies that quantify the parenchyma macrophage turnover rate during Mtb infection (348) 
could hint at new mechanisms by which parenchyma macrophages and other innate cells (350) 
could act in wound repair/healing and re-establishment of a certain degree of quiescence in the 
lung after antibiotic treatment. 
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Innate immune cell recruitment is not only influenced by cell death (146), but also by 
biomolecules (71), and these recruited cells secrete cytokines and growth factors (63) that 
influence the recruited adaptive immune cells. In agreement with cytokine/chemokine studies 
carried out in active TB patients (351, 352) and other experimental animal models (63, 71), a 
pro-inflammatory response was exhibited by increased levels of TNF-a, IFN-g, IL-6 and IL-1b in 
the HIS NSG lung homogenates on the protein level as the disease progressed. These cytokines 
are associated with a Th1 response. Other pulmonary cytokines that increased throughout the 
disease were the Th2 associated IL-9 and the T-reg associated IL-10 hinting at a subliminal anti-
inflammatory response. In addition, pulmonary chemokines that also increased as the disease 
progressed were IP-10, MIP-1a and interestingly, the human specific pro-inflammatory IL-8 
chemokine.  
To my knowledge, this is the first study that has kinetically followed human IL-8 in vivo in TB, as 
studies investigating the role of IL-8 in tuberculosis and other diseases have primarily been done 
in human cells or guinea pigs (353). Mice do not have a gene that codes for IL-8 hence murine 
homologues are used as functional equivalents (354). IL-8 is a chemokine that is secreted by 
cells such as the macrophage and plays a major role in neutrophil recruitment (355). IL-8 is of 
great interest in the human TB field as there have been studies that link a dominant IL-8 allele to 
increased susceptibility to Mtb particularly in individuals of African descent (356). From the data 
gathered in this thesis, some speculations for the role of IL-8 in active progressive disease could 
be put forth as follows. In the first stage, IL-8 directly binds to Mtb and these binding increases 
the phagocytic capability of macrophages and neutrophils (357). Secondly, the neutrophils 
secrete more IL-8 and other chemokines such as MIP-1a and MCP-1 (358). The initial amount of 
IL-8 secreted during this first stage is beneficial as IL-8 and the other chemokines attract DCs 
and monocytes/macrophages to interact with various neutrophils. However, in the later stages 
of the disease whence the amount of IL-8 is still high, this becomes detrimental as an excessive 
number of neutrophils will release free radicals, proteases and elastase causing major tissue 
damage (359).  Surprisingly, another cytokine of interest in human TB, the IL-17cytokine was not 
detected in the HIS NSG lung homogenates. This was especially surprising as IL-17 has been 
associated with neutrophil recruitment that causes severe TB (360) as exhibited by the caseous 
necrotic granulomas. Perhaps, the luminex kit used had low sensitivity for detecting IL-17 or 
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perhaps by using the lab strain Mtb H37RV, certain virulence factors that would induce high 
levels of IL-17 as seen in a study that used virulent Mtb HN878 (113) were absent. In order to 
quantify and visualize IL-17 as the disease progresses, future experiments could incorporate a 
highly sensitive ELISA and chromogenic analysis on the HIS NSG lung tissue sections for visual 
confirmation of IL-17 and other biomolecules with their associated cells (362). 
In this thesis, there was an influx of B cells in the HIS NSG lungs post Mtb infection and these B 
cells were located in the outer lymphocyte cuff, interspersed with the T cells. These B cells in 
HIS NSG lung were not organized into lymphoid follicular like structures as seen in some NHP 
(139) and human TB granulomas (130). As the NSG strain lacks certain cytokines and growth 
factors that aid in the development of proper lymphnodes, there is the possibility that the 
human B cells that are generated in the HIS NSG system, do not have the right scaffold which 
will permit them to form aggregates with the T cells to ensure optimal antigen presentation and 
activation. B cell associated biomolecules such as IL-6 and IgA increased from day 14 to day 28 
in the HIS NSG lung post Mtb infection. IL-6 production could initially aid in increasing the T cell 
response (129, 361), but later on be a factor in causing severe pathology as observed in 
autoimmune diseases such as multiple sclerosis (363). As previously stated, there was an 
increase in lung bacterial burden in spite of the high IgA levels.  The IgA antibody produced in 
the HIS NSG system could be of low functionality, as two recent studies showed that antibodies 
from latent TB individuals were better at phagolysosome fusion, had enhanced macrophage 
killing of Mtb and inflammasome activation in comparison to active TB patients (364, 365).  
The T cells in particular the human CD45+CD3+CD4+ T cells were the largest number of adaptive 
immune cells in the HIS NSG lung post Mtb infection and were intermingled with the B cells and 
the human CD45+CD3+CD8+ T cells in the outer lymphocyte cuff (130, 139). The CD4 T cells 
during the initial phase of the infection first surround small aggregates of innate immune cells 
probably to enhance innate immune cell killing mechanisms via the production of INF-γ and 
TNF-α (110). The CD8 T cells also enhance innate immune cell killing mechanisms during the 
initial phase of the infection via the production of cytokines; but it is also probable that the CD8 
T cells release cytotoxic molecules such as the granzymes, perforin and granulysin to destroy 
infected innate immune cells (123). As previously mentioned, there is a high bacterial burden in 
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the HIS NSG lung, leading to the speculation that even though there are a significant number of 
T cells recruited to the lung, the response generated is inadequate. Factors that could have 
contributed to this inadequate response are low T cell activation or T cell anergy as seen by the 
Il12p70 which is a cytokine linked to T cell activation was unchanged throughout the time 
course. Other factors that could have caused this inadequate response are an impaired 
antigenic specific response by the CD4 granuloma associated T cells (167), impairment in CD8 
granuloma associated T cells in releasing cytotoxic molecules (125) or due to the lack of human 
HLA in the HIS NSG system (190). Moreover, the balance of pro and anti-inflammatory cytokines 
in the bulk HIS NSG lung is skewed towards the pro-inflammatory side with a more pro- 
signature linked to higher bacterial burden (351). In fact a recent NHP study, showed that 
individual granulomas that had T cells that secreted both pro and anti-inflammatory cytokines 
upon a certain Mtb antigen combination had greater bacterial clearance suggesting that a 
balance between pro and anti-inflammatory cytokines is necessary to control bacterial 
replication and that future HIS NSG Mtb studies should include NSG strains with enhanced 
features (366) such as human transgenic cytokine and human HLAs in order to properly asses 
the functionality and the Mtb specific responses of the various human immune cells.  
Not only was an immune response generated in the lung, there was also an immune response 
generated in other organs such as the spleen and the bone marrow. Concurrent to an immune 
response generated in these organs, bacteria dissemination occurred in a manner similar to 
cancer metastasis from the primary site to other organs (371). A possible speculation of how 
this occurs in the HIS NSG mouse system; is that after the granuloma has been established, 
dendritic cells and other innate immune cells not only migrate to the lymphnodes for T cell 
activation (100), but also to other organs such as the spleen and bone marrow via the 
lymphatics and via newly created blood vessels (372). Indeed, there was an increase in VEGF in 
the HIS NSG lung post Mtb infection which gives credence to the possible induction of 
angiogenesis by Mtb in order to maximize the survival rate of the bacteria in the host (373). 
Hence, not only was there an influx of innate and adaptive cells in organs such as the spleen, but 
the immune cells were organized in a caseous necrotic granuloma pathology by day 28 post 
infection as a means to contain the infection. However, due to the systemic bacterial infection 
occurring throughout the HIS NSG body, it is possible that a form of emergency granulopoiesis 
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(374) is taking place as seen by the low neutrophil numbers in the bone marrow in relation to 
the high neutrophil numbers in the lung. Such excessive granulopoiesis occurs in the bone 
marrow due to factors such as cytokines/chemokines influencing the haematopoietic stem cells 
(375) or by direct infection of the stem cells (376). Thus, there is an increasing realization in the 
TB field that the bone marrow has a role in Mtb infection, not only as a site that aids in 
replenishing immune cells in the lungs, but also as a reservoir for Mtb by the infection of non-
haematopoietic mesenchymal stem cells (377). This could also explain the long treatment times 
and reactivation that is observed in certain TB patients, thus future HIS NSG studies that will 
compare novel TB drugs would include assays that check for drug penetrance in the lung 
granuloma (378) and in the bone marrow itself. 
Concluding notes 
Collectively, my thesis has shown the first human fetal liver derived stem cell humanized mouse 
for the study of tuberculosis and its associated pathology. Using the figure below as a guide of 
where my data stands in the present state of the TB field (Figure 35 box), I have confirmed that 
low dose aerosolized infection occurs, that there are signs of active disease, that various lesions 
and granulomas do develop, and in particular that caseous necrotic granulomas develop. The 
data I have presented in this thesis was mainly shows the basic immune cell phenotypes, their 
basic cellular-spatial organization and certain biomolecules; on the organ scale, tissue scale and 
the cellular scale. 
With new technologies such as inductively coupled plasma mass spectrometry (ICP-MS) 
commonly known as CYTOF, it is now possible to apply 100 markers simultaneously on the same 
sample. Therefore, not only can the classically studied immune cells be categorized by activation 
status and other markers of interest, but; rare combinational cell types such as the innate 
lymphoid cells and myeloid derived suppressor cells (379) can be easily examined. CYTOFs can 
also have a laser attached to ablate tissue sections which permits direct local imaging of the 
immune cells (367). 
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Figure35. Possibility to study cellular and molecular mechanisms of TB in HIS NSG mice (Source: Courtesy of 
Professor S.H.E. Kaufmann) 
As more biomarkers specific for tuberculosis are being accepted (381), future HIS NSG studies 
could include transcriptomics, proteomics, metabolomics and epigenomics in order to 
understand tuberculosis on the molecular scale in this system (380). Furthermore, there is now 
a move in the humanized mouse/infectious disease field to switch to enhanced NSG strains with 
transgenic human cytokines (IL-3, GM-CSF and CSF1) which have more functional human 
myeloid cells upon engraftment or NSG strains with transgenic human HLAs that develop more 
functional human T cells upon engraftment (368). Using these enhanced strains will not only 
permit the confirmation of key cellular and molecular mechanisms to TB in individual 
granulomas (369), but also the ways by which these mechanisms are changed due to drugs 
(253), HDTs (370), therapeutic vaccines (111) and HIV co-infection (162). 
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Abbreviations 
Mtb                                Mycobacterium tuberculosis  
TB                                   Tuberculosis  
HIV                                 Human Immunodeficiency Virus  
BCG                                Bacille Calmette- Guérin  
Hly                                  listeriolysin gene  
PPD                                purified protein derivative  
IGRAs                             Interferon-Gamma Release Assays  
ESAT-6                           6 kDa early secretory antigenic target 
CFP-10                           10 kDa culture filtrate antigen  
RD1                                region of difference 1  
SLE                                  systemic lupus erythematosus  
MDR-TB                         multi-drug resistant tuberculosis  
XDR-TB                          extensively drug resistant tuberculosis strains  
(TDR-TB)                        totally drug resistant tuberculosis  
IFN-γ                              interferon gamma  
IL                                     interleukin   
PET                                 positron emission tomography  
CT                                   compututerized tomography  
SPECT                             single photon emission computed tomography  
Pa                                       pretomanid  
M                                       moxifloxacin  
Z                                         pyrazinamide  
HDTs                                  host directed therapies  
GAMs                                granuloma associated macrophages  
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NHPs                                 Non-human primates  
SIV                                     Simian Immune deficiency virus  
FDG                                   2-deoxy-2-(18F)-fluoro-D-glucose  
CFU                                colony forming unit  
M. bovis                            Mycobacterium bovis  
M. marinium                    Mycobacterium marinium  
Ipr-1                                  intracellular pathogen resistance 1  
sst-1                                  super susceptibility to tuberculosis 1  
iNOS                                  inducible nitric oxide  
TNF-α                                tumor necrosis factor alpha  
PAMPs                              pathogen- associated molecular patterns  
LM                                     lipomannan  
ManLam                           mannose-capped Lipoarabinomannan  
PIMs                                  phosphatidyl-myo-inositol mannosides  
PRRs                                  pattern recognition receptors  
TLRs                                   Toll like receptors  
CRs                                    complement receptors  
MRs                                   mannose receptors  
SRs                                     scavenger receptors  
DC-SIGN              Dendritic cell-specific intracellular adhesion molecule-3-Grabbing non-integrin  
AECs                                  Airway epithelial cells  
DCs                                    dendritic cells  
CCL                                    Chemokine motif ligand  
CXCL                                  C-X-C motif chemokine ligand  
ROI                                     reactive oxygen intermediates  
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RNI                                     reactive nitrogen intermediates  
NO                                      nitrogen oxide  
ESX                                     early secreted antigen 6 kilodaltons (ESAT-6) secretion system  
MMP-9                              matrix metalloproteinase 9  
APCs                                  antigen presenting cells  
MHC                                  major histocompatibility class   
LFA-1                                 lymphocyte function-associated antigen 1  
ICAM-1                              intercellular adhesion molecule 1  
MSMD                               Mendelian susceptibility to mycobacterial disease  
IFNGR1                              IFNγ receptor 1  
STAT1                                Signal Transducers and Activators of Transcription 1  
IL12RB1                             IL-12 receptor β1  
NEMO                               nuclear factor-κB (NF-κB) essential modulator  
CYBB                                  cytochrome b-245  
IRF8                                   interferon regulatory factor 8  
HMBPP                             (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate phosphoantigen  
NKs                                    natural killer cells  
Th                                       T-helper  
T regs                                regulatory T cells  
TGF-b1                              transforming growth factor-beta 1  
gdTs                                   gamma delta T cells  
CTLs                                   cytolytic T cells  
MAITs                                mucosal associated invariant T cells  
ROS                                    reactive oxygen species  
NETS                                  neutrophil extracellular traps  
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Eis                                      enhanced intracellular survival gene  
nuoG                                 NADH-quinone oxidoreductase subunit G  
LXA4                                  lipoxin A4  
PGE2                                 prostaglandin E2  
PBMCs                              peripheral blood mononucelear cells  
BAL                                    bronchoalveolar lavage  
SCID                                   severe combined immunodeficiency mutation  
NOD                                  non-obese diabetic  
Rag1                                  recombination-activation gene 1  
IL-2Rg                                interleukin 2 receptor gamma chain  
BRG                                   BalbC Rag2 null IL-2R gamma null  
NSG                                   NOD SCID IL-2 receptor gamma null  
NRG                                   NOD Rag1 null IL-2 receptor gamma null  
SIRPa                                 signal regulatory protein alpha  
HSCs                                  hematopoietic stem cell  
HPCs                                  hematopoietic stem and progenitor cells  
HLA                                    human leukocyte antigen  
Hu-HSC                             Human hematopoietic stem cell  
HIS                                     Human Immune System  
PBL                                    peripheral blood leukocytes  
BLT                                    bone marrow-liver-thymus  
SDF-1                                 stromal derative factor 1  
Hu-Hep                             Hu-hepatocyte  
CD                                      cluster of differentiation 
CaCl2                                  Calcium chloride 
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MgCl2                                   Magnesium chloride 
RT                                          room temperature  
BD                                         Beckton Dickson 
BSA                                       bovine serum albumin 
MNC                                     mono-nuclear cell layer  
FACs                                      fluorescence-activated cell sorting  
FMO                                     fluorescent minus one  
ADC                                       albumin dextrose catalase 
WHO                                     World Health Organization 
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